<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic" pub-type="epub">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">81290</article-id><article-id pub-id-type="doi">10.7554/eLife.81290</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Chromosomes and Gene Expression</subject></subj-group><subj-group subj-group-type="heading"><subject>Developmental Biology</subject></subj-group></article-categories><title-group><article-title>Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-284615"><name><surname>San Martin</surname><given-names>Rebeca</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0001-7249-3922</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund2"/><xref ref-type="fn" rid="con1"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284616"><name><surname>Das</surname><given-names>Priyojit</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0002-6774-6718</contrib-id><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="con2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-284617"><name><surname>Sanders</surname><given-names>Jacob T</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="con3"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-284618"><name><surname>Hill</surname><given-names>Ashtyn M</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="con4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-103762"><name><surname>McCord</surname><given-names>Rachel Patton</given-names></name><contrib-id authenticated="true" contrib-id-type="orcid">https://orcid.org/0000-0003-0010-5323</contrib-id><email>rmccord@utk.edu</email><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="other" rid="fund1"/><xref ref-type="fn" rid="con5"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/020f3ap87</institution-id><institution>Department of Biochemistry &amp; Cellular and Molecular Biology, University of Tennessee at Knoxville</institution></institution-wrap><addr-line><named-content content-type="city">Knoxville</named-content></addr-line><country>United States</country></aff><aff id="aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/020f3ap87</institution-id><institution>UT-ORNL Graduate School of Genome Science and Technology, University of Tennessee at Knoxville</institution></institution-wrap><addr-line><named-content content-type="city">Knoxville</named-content></addr-line><country>United States</country></aff><aff id="aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00t9vx427</institution-id><institution>Department of Pathology, University of Texas Southwestern Medical Center</institution></institution-wrap><addr-line><named-content content-type="city">Dallas</named-content></addr-line><country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ackert-Bicknell</surname><given-names>Cheryl</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jc20583</institution-id><institution>University of Colorado</institution></institution-wrap><country>United States</country></aff></contrib><contrib contrib-type="senior_editor"><name><surname>Isales</surname><given-names>Carlos</given-names></name><role>Senior Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/012mef835</institution-id><institution>Augusta University</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><pub-date publication-format="electronic" date-type="publication"><day>29</day><month>12</month><year>2022</year></pub-date><pub-date pub-type="collection"><year>2022</year></pub-date><volume>11</volume><elocation-id>e81290</elocation-id><history><date date-type="received" iso-8601-date="2022-06-22"><day>22</day><month>06</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-12-29"><day>29</day><month>12</month><year>2022</year></date></history><pub-history><event><event-desc>This manuscript was published as a preprint at .</event-desc><date date-type="preprint" iso-8601-date="2022-06-21"><day>21</day><month>06</month><year>2022</year></date><self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2022.06.21.497024"/></event></pub-history><permissions><copyright-statement>© 2022, San Martin et al</copyright-statement><copyright-year>2022</copyright-year><copyright-holder>San Martin et al</copyright-holder><ali:free_to_read/><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><ali:license_ref>http://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-81290-v2.pdf"/><self-uri content-type="figures-pdf" xlink:href="elife-81290-figures-v2.pdf"/><abstract><p>The expression of a mutant Lamin A, progerin, in Hutchinson-Gilford Progeria Syndrome leads to alterations in genome architecture, nuclear morphology, epigenetic states, and altered phenotypes in all cells of the mesenchymal lineage. Here, we report a comprehensive analysis of the transcriptional status of patient derived HGPS fibroblasts, including nine cell lines not previously reported, in comparison with age-matched controls, adults, and old adults. We find that Progeria fibroblasts carry abnormal transcriptional signatures, centering around several functional hubs: DNA maintenance and epigenetics, bone development and homeostasis, blood vessel maturation and development, fat deposition and lipid management, and processes related to muscle growth. Stratification of patients by age revealed misregulated expression of genes related to endochondral ossification and chondrogenic commitment in children aged 4–7 years old, where this differentiation program starts in earnest. Hi-C measurements on patient fibroblasts show weakening of genome compartmentalization strength but increases in TAD strength. While the majority of gene misregulation occurs in regions which do not change spatial chromosome organization, some expression changes in key mesenchymal lineage genes coincide with lamin associated domain misregulation and shifts in genome compartmentalization.</p></abstract><kwd-group kwd-group-type="author-keywords"><kwd>3D genome folding</kwd><kwd>transcriptomics</kwd><kwd>premature aging</kwd></kwd-group><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Human</kwd></kwd-group><funding-group><award-group id="fund1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000057</institution-id><institution>National Institute of General Medical Sciences</institution></institution-wrap></funding-source><award-id>R35GM133557</award-id><principal-award-recipient><name><surname>McCord</surname><given-names>Rachel Patton</given-names></name></principal-award-recipient></award-group><award-group id="fund2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000048</institution-id><institution>American Cancer Society</institution></institution-wrap></funding-source><award-id>134060-PF-19-183-01-CSM</award-id><principal-award-recipient><name><surname>San Martin</surname><given-names>Rebeca</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group><custom-meta-group><custom-meta specific-use="meta-only"><meta-name>Author impact statement</meta-name><meta-value>Age-stratified comparisons of gene expression in progeria patient fibroblasts reveals disruption of mesenchymal lineage pathways and points to a deficit in chondrogenic commitment in early development and a depletion of the mesenchymal lineage stem cell pool.</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="s1" sec-type="intro"><title>Introduction</title><p>Hutchinson-Gilford progeria syndrome (HPGS) is a rare disease, characterized by a severe premature aging phenotype (<xref ref-type="bibr" rid="bib27">Gilford and Hutchinson, 1897</xref>; <xref ref-type="bibr" rid="bib36">Hutchinson, 1886</xref>). Patients appear normal at birth, with a disease onset around 2 years of age when they present with slow growth rate, short stature, and marked lipodystrophy with a characteristic loss of subcutaneous fat. With progression, patients experience arthritis, joint contracture, osteoporosis and stiffening of blood vessels. Average life expectancy for HPGS patients is 13.4 years, with myocardial infarction and stroke being the predominant causes of death (<xref ref-type="bibr" rid="bib26">Foundation, 2019</xref>).</p><p>HGPS is caused by a thymidine substitution mutation at cytidine 608 (GGC &gt;GGT), within exon 11 of the gene that encodes for Lamin A (LMNA) (<xref ref-type="bibr" rid="bib18">De Sandre-Giovannoli et al., 2003</xref>; <xref ref-type="bibr" rid="bib23">Eriksson et al., 2003</xref>). Lamin A is a structural protein of the nuclear envelope, playing an important role in genome structure and nuclear integrity. The mutation does not result in an amino acid substitution, frame shift or early termination. Rather, it induces the usage of a cryptic splice site and the subsequent deletion of 50 amino acids at the C terminus. In turn, this deletion impedes downstream processing of the protein and results in conservation of C terminus farnesylation (<xref ref-type="bibr" rid="bib15">Davies et al., 2009</xref>). This abnormal protein product is called Progerin. Aggregation of Progerin leads to a disruption of the normal nuclear envelope meshwork, leading to deformed nuclei, nuclear stiffening, and defective mechanotransduction (<xref ref-type="bibr" rid="bib4">Apte et al., 2017</xref>; <xref ref-type="bibr" rid="bib28">Goldman et al., 2004</xref>; <xref ref-type="bibr" rid="bib48">Lammerding et al., 2004</xref>).</p><p>Of particular interest, progeria patients present with various defects in all tissues of the mesenchymal lineage. Specifically, regarding bone physiology, patients show reduced stature, generalized osteopenia, thin calvaria, and clavicle regression with absence of medial and lateral ends, as well as resorption of the distal bony phalanges and anterior ribs (<xref ref-type="bibr" rid="bib9">Chawla et al., 2017</xref>; <xref ref-type="bibr" rid="bib10">Cleveland et al., 2012</xref>; <xref ref-type="bibr" rid="bib32">Gordon et al., 2011</xref>; <xref ref-type="bibr" rid="bib62">Nazir et al., 2017</xref>). These phenotypes are more striking when considering that at birth, bone structure appears normal. Previous observations, where fibroblasts from progeria patients showed abnormal levels of aggrecan (<xref ref-type="bibr" rid="bib52">Lemire et al., 2006</xref>) a marker of chondrogenic differentiation, led us to hypothesize that fibroblasts derived from HGPS patients – themselves a cell of the mesenchymal lineage – could harbor vestigial transcriptional signatures to abnormal mesenchymal stem cell commitment, which would become apparent by comparing them with different normal age group controls.</p><p>In this study, we conduct a comprehensive analysis of previously published RNA-seq datasets for HPGS fibroblast cells harboring the typical C&gt;T mutation in the LMNA gene and provide transcriptomics data for nine patient fibroblast samples that had no previously reported RNA-seq data. By comparing the transcriptional profile of HPGS fibroblasts (33 datasets, 21 patients, 1–20 years old) with fibroblasts derived from age-matched controls (21 datasets, 16 donors, 1–19 years old), healthy adults, (16 donors, 26–43 years old) and healthy old adults (15 donors, 80–96 years old), we provide insight into important defects in repair biology, metabolism (calcium, lipid), and other areas important to the mesenchymal cell lineage. Our results show that transcription of genes involved in negative regulation of chondrocyte commitment is compromised in fibroblasts from patients that are at the age of onset of postnatal endochondral ossification. We report that some genes central to differentiation commitment into the chondrogenic-osteogenic lineage and identified as misregulated in this study (PTHLH, BMP4, FZD4, and IGF1) show either abnormal genomic architecture or lamin associated domain alterations.</p><p>Our results support the hypothesis that defects in the initial steps of chondrogenesis commitment are a potential mechanism for mesenchymal stem cell depletion that later results in abnormal adipogenesis, diminished microvasculature homeostasis, and poor wound repair observed in HGPS patients.</p></sec><sec id="s2" sec-type="results"><title>Results</title><sec id="s2-1"><title>Batch correction is essential for comparison among patient and normal cohorts</title><p>To determine gene sets that were consistently misregulated in Progeria fibroblasts, we collected both newly generated and previously published RNA-seq data from all available Progeria patient fibroblast cell samples as well as fibroblasts from control individuals in different age groups (<xref ref-type="table" rid="app1table3 app1table1 app1table2">Appendix 1—tables 1–3</xref>; <xref ref-type="bibr" rid="bib25">Fleischer et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Ikegami et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Köhler et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Mateos et al., 2018</xref>). When the resulting transcriptomics data were analyzed by principal component analysis (PCA), datasets clustered according to laboratory of origin regardless of diagnosis, making direct comparisons impossible (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1A</xref>), as has been previously observed in Progeria transcriptomics analysis (<xref ref-type="bibr" rid="bib37">Ikegami et al., 2020</xref>) However, after batch effect correction (materials and methods <xref ref-type="bibr" rid="bib84">Zhang et al., 2020a</xref>), the first principal component was able to segregate the samples depending on progeria/non progeria origin (<xref ref-type="fig" rid="fig1s1">Figure 1—figure supplement 1B</xref>) which enabled direct comparisons between patients and controls from different age groups which originated from different sources.</p></sec><sec id="s2-2"><title>Gene ontology analysis of transcriptional changes reveals eight clusters of biological activity affected in HGPS</title><p>To derive sets of genes differentially regulated in Progeria, we divided the patient samples into Young (0–8 years old) and Teen (&gt;13 years old) categories based on the idea that different developmental processes take place in these age groups. We then compared each patient group to age-matched controls, middle-aged adults, and older adults and selected up and down-regulated genes (FDR adjusted <italic>P</italic>-value &lt;0.001) for gene ontology analysis. Teenage HGPS patients showed the smallest number of genes changing expression levels when compared to age-matched controls, but the highest number of genes up/down regulated when compared to healthy middle-aged or old adults (<xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="supplementary-material" rid="table1sdata1">Table 1—source data 1</xref>). Importantly, comparisons between the normal children cohort and the adult normal controls yield few significant changes, suggesting that HGPS is the driver of the differences observed among cohorts.</p><table-wrap id="table1" position="float"><label>Table 1.</label><caption><title>Number of up/down-regulated genes per age comparisons.</title><p><supplementary-material id="table1sdata1"><label>Table 1—source data 1.</label><caption><title>Metascape outputs for gene ontology analysis.</title><p>Childhood and teenaged patient samples compared to middle aged and older adults.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-81290-table1-data1-v2.zip"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Comparisons</th><th align="left" valign="top">Upregulated genes</th><th align="left" valign="top">Downregulated genes</th></tr></thead><tbody><tr><td align="left" valign="top">Young patients – Age matched</td><td align="char" char="." valign="top">260</td><td align="char" char="." valign="top">63</td></tr><tr><td align="left" valign="top">Young patients – Adult control</td><td align="char" char="." valign="top">574</td><td align="char" char="." valign="top">241</td></tr><tr><td align="left" valign="top">Young patients – Old adult control</td><td align="char" char="." valign="top">984</td><td align="char" char="." valign="top">435</td></tr><tr><td align="left" valign="top">Teenaged patients – Age matched</td><td align="char" char="." valign="top">237</td><td align="char" char="." valign="top">81</td></tr><tr><td align="left" valign="top">Teenaged patients – Adult control</td><td align="char" char="." valign="top">1873</td><td align="char" char="." valign="top">1138</td></tr><tr><td align="left" valign="top">Teenaged patients – Old adult control</td><td align="char" char="." valign="top">1872</td><td align="char" char="." valign="top">1022</td></tr><tr><td align="left" valign="top"/><td align="left" valign="top"/><td align="left" valign="top"/></tr><tr><td align="left" valign="top">Young Control – Adult Control</td><td align="char" char="." valign="top">28</td><td align="char" char="." valign="top">25</td></tr><tr><td align="left" valign="top">Young Control – Old Control</td><td align="char" char="." valign="top">817</td><td align="char" char="." valign="top">421</td></tr></tbody></table></table-wrap><p>Overall, relevant gene ontology terms identified in the study pertain to eight functional clusters: DNA maintenance and Epigenetics (<xref ref-type="fig" rid="fig1">Figure 1</xref>), Repair and Extracellular matrix (<xref ref-type="fig" rid="fig2">Figure 2</xref>), Bone (<xref ref-type="fig" rid="fig3">Figure 3</xref>), Adipose Tissue (<xref ref-type="fig" rid="fig4">Figure 4</xref>), Blood Vessels (<xref ref-type="fig" rid="fig5">Figure 5</xref>), and Muscle (<xref ref-type="fig" rid="fig6">Figure 6</xref>).</p><fig-group><fig id="fig1" position="float"><label>Figure 1.</label><caption><title>Transcriptional misregulation in the DNA Maintainance and Epigenetics functional categories.</title><p>(<bold>A</bold>) Summary table of processes related to DNA maintenance and epigenetics, represented as transcriptional up or downregulation based on RNA-seq of young/teenager progeria patient derived fibroblasts compared to age matched, middle age or old control patients. (<bold>B</bold>) Heat map of RNA-seq transcriptome analysis for 976 selected genes related to DNA maintenance and epigenetics. The heat map shows per-gene z-score computed from batch effect corrected log2 read count values, genes in rows and 29 patient samples (progeria and young/adult/old control) organized in columns. Genes were hierarchically clustered based on Euclidean distance and average linkage. Within each cohort, columns are organized by patient age. (<bold>C</bold>) Comparison of young progeria patients versus middle age or old donor control fibroblasts. Enriched ontology clusters for upregulated genes related DNA maintenance and epigenetics, as characterized by Metascape analysis. Metascape reports p-values calculated based on the hypergeometric distribution. (<bold>D</bold>) Comparison of teen-aged progeria patient fibroblast versus old donor control fibroblasts. Enriched ontology clusters for up regulated genes related to DNA maintenance and epigenetics, as characterized by Metascape analysis.</p><p><supplementary-material id="fig1sdata1"><label>Figure 1—source data 1.</label><caption><title>RNA-seq results: normalized and batch corrected sequencing counts for all samples in this study.</title></caption><media mimetype="application" mime-subtype="octet-stream" xlink:href="elife-81290-fig1-data1-v2.csv"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig1-v2.tif"/></fig><fig id="fig1s1" position="float" specific-use="child-fig"><label>Figure 1—figure supplement 1.</label><caption><title>Batch clustering correction.</title><p>(<bold>A</bold>) Principal component analysis (PCA) of the datasets used in this study before batch correction. Samples segregate primarily by lab of origin (red circles). Solid color markers: Progeria, hollow markers: normal controls, triangles: female, circles: male. (<bold>B</bold>) PCA after batch correction. Samples primarily segregate by progeria/control phenotype. Dotted line denotes an arbitrary margin between cohorts. Solid color markers: Progeria, hollow markers: normal controls, triangles: female, circles: male. Purple circles denote patients that are mismatched from the rest of their respective groups.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig1-figsupp1-v2.tif"/></fig></fig-group><fig id="fig2" position="float"><label>Figure 2.</label><caption><title>Transcriptional misregulation in tissue repair and extracellular matrix functional categories.</title><p>(<bold>A</bold>) Heat map of RNA-seq transcriptome analysis for 585 selected genes related to repair. Data presented as in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. (<bold>B</bold>) Heat map of RNA-seq transcriptome analysis for 145 selected genes related to extra cellular matrix. Data presented as in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. (<bold>C</bold>) Summary table of processes related to repair and extra cellular matrix organization, represented as up or downregulation in transcription based on RNA-seq of young/teenager progeria patient derived fibroblasts, compared to middle age or old control patients. Age comparisons that yielded no significant results in relevant categories are not shown.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig2-v2.tif"/></fig><fig id="fig3" position="float"><label>Figure 3.</label><caption><title>Transcriptional misregulation for genes related to bone development.</title><p>(<bold>A</bold>) Summary table of processes related to bone and cartilage development and homeostasis represented as up or downregulated transcription based on RNA-seq of young progeria patient derived fibroblasts compared to age matched, middle age or old control patients. (<bold>B</bold>) Heat map of RNA-seq transcriptome analysis for 165 selected genes related to bone and cartilage development. Data presented as in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. (<bold>C</bold>) Comparison of young progeria patients versus old donor control fibroblasts. Enriched ontology clusters for upregulated genes related bone and cartilage development and homeostasis, as characterized by Metascape analysis. (<bold>D</bold>) Comparison of young progeria patients versus old donor control fibroblasts. Enriched ontology clusters for downregulated genes related to cation homeostasis, as characterized by Metascape analysis. (<bold>E</bold>) Comparison of young progeria patients versus middle age control fibroblasts. Enriched ontology clusters for downregulated genes related to bone development and homeostasis, as characterized by Metascape analysis.</p><p><supplementary-material id="fig3sdata1"><label>Figure 3—source data 1.</label><caption><title>Gene expression analysis (Z-scores) for 164 genes related to bone development.</title></caption><media mimetype="application" mime-subtype="octet-stream" xlink:href="elife-81290-fig3-data1-v2.csv"/></supplementary-material></p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig3-v2.tif"/></fig><fig id="fig4" position="float"><label>Figure 4.</label><caption><title>Transcriptional missregulation in genes related to adipose tissue function and development.</title><p>(<bold>A</bold>) Summary table of processes related to fat cell differentiation and lipid metabolism, represented as up or downregulation in transcription based on RNA-seq of young/teenager progeria patient derived fibroblasts, compared to age matched, middle age, or old control patients. (<bold>B</bold>) Heat map of RNA-seq transcriptome analysis for 134 selected genes related to fat cell differentiation and lipid metabolism. Data presented as in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. (<bold>C</bold>) Comparison of young progeria patients versus middle age or old donor control fibroblasts. Enriched ontology clusters for upregulated genes related to fat and lipid metabolism, as characterized by Metascape analysis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig4-v2.tif"/></fig><fig id="fig5" position="float"><label>Figure 5.</label><caption><title>Transcriptional missregulation in genes related to blood vessel homeostasis.</title><p>(<bold>A</bold>) Summary table of processes related to blood vessel homeostasis, represented as up or downregulation in transcription based on RNA-seq of young/teenager progeria patient derived fibroblasts, compared to age matched, middle age, or old control patients. (<bold>B</bold>) Heat map of RNA-seq transcriptome analysis for 131 selected genes related to blood vessel homeostasis. Data presented as in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. (<bold>C</bold>) Comparison of young progeria patients versus middle-aged donor control fibroblasts. Enriched ontology clusters for upregulated genes related to blood vessel development, as characterized by Metascape analysis. (<bold>D</bold>) Comparison of teen-aged progeria patient fibroblast versus age-matched control fibroblasts. Enriched ontology clusters for upregulated genes related to blood vessel development, as characterized by Metascape analysis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig5-v2.tif"/></fig><fig id="fig6" position="float"><label>Figure 6.</label><caption><title>Transcriptional missregulation in genes related to muscle function.</title><p>(<bold>A</bold>) Summary table of processes related to muscle and cardiac muscle development, represented as up or downregulation in transcription based on RNA-seq of young/teenager progeria patient derived fibroblasts, compared to middle age or old control patients. (<bold>B</bold>) Heat map of RNA-seq transcriptome analysis for 261 selected genes related to muscle development. Data presented as in <xref ref-type="fig" rid="fig1">Figure 1B</xref>. (<bold>C</bold>) Comparison of young progeria patients versus middle-aged and old donor control fibroblasts and of teen-aged progeria patients versus old donor controls. Enriched ontology clusters for upregulated genes related to muscle development, as characterized by Metascape analysis.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig6-v2.tif"/></fig><p>The largest number of differentially expressed genes (Nine hundred and seventy) were related to the biological processes of epigenetic programming and DNA maintenance (<xref ref-type="fig" rid="fig1">Figure 1A</xref> and <xref ref-type="supplementary-material" rid="fig1sdata1">Figure 1—source data 1</xref>). Gene ontology pathways included in this cohort include epigenetic regulation of gene silencing, senescence-associated heterochromatin, DNA repair, DNA recombination, and histone methylation/modifications. This is in line with extensive previous evidence of epigenetic and DNA repair misregulation in Progeria (<xref ref-type="bibr" rid="bib1">Aguado et al., 2019</xref>; <xref ref-type="bibr" rid="bib31">Gonzalo and Coll-Bonfill, 2019</xref>; <xref ref-type="bibr" rid="bib61">Misteli and Scaffidi, 2005</xref>). These genes were predominantly over-expressed in young progeria patients when compared to all controls (<xref ref-type="fig" rid="fig1">Figure 1B,C</xref>) and between teenaged patients compared to their age matched control and adults (<xref ref-type="fig" rid="fig1">Figure 1B,D</xref>).</p><p>The next biological process with the most misregulated transcription among age groups was tissue repair. It bears mentioning that most of the nucleosome-associated proteins and histones identified in the DNA maintenance cluster, as previously described, overlap with the repair GO terms. In all, 585 genes are differentially expressed between cohorts (<xref ref-type="fig" rid="fig2">Figure 2A</xref>), with HGPS patients predominantly overexpressing targets pertaining to the organization of the extracellular matrix (145 genes, <xref ref-type="fig" rid="fig2">Figure 2B</xref>). Interestingly, signatures related to coagulation, Bone Morphogenic Protein signaling, and response to wound healing are all downregulated in young HGPS patients when compared to adults (<xref ref-type="fig" rid="fig2">Figure 2C</xref>).</p><p>In this analysis of fibroblasts, we also identified misregulation of gene targets typically associated with the biology of mesenchymal tissue. Specifically, we see misregulation of transcription of genes involved in bone (165 genes. <xref ref-type="fig" rid="fig3">Figure 3</xref>), fat (261 genes. <xref ref-type="fig" rid="fig4">Figure 4</xref>), blood vessel homeostasis (131 genes. <xref ref-type="fig" rid="fig5">Figure 5</xref>), and muscle (261 genes. <xref ref-type="fig" rid="fig6">Figure 6</xref>). All these lineages have been observed as compromised in HGPS patients, showing phenotypes like osteopenia, early atherosclerosis, and lack of subcutaneous fat deposition. (<xref ref-type="bibr" rid="bib32">Gordon et al., 2011</xref>; <xref ref-type="bibr" rid="bib34">Hamczyk et al., 2018</xref>; <xref ref-type="bibr" rid="bib81">Xiong et al., 2013</xref>).</p><p>Bone biology mis-regulation appears to be stratified into two distinct hubs: downregulation of pathways related to calcium homeostasis and transport and upregulation of pathways involved in cell differentiation of chondrocytes and osteoblasts (<xref ref-type="fig" rid="fig3">Figure 3A,B</xref> and <xref ref-type="supplementary-material" rid="fig3sdata1">Figure 3—source data 1</xref>). Comparing young patients’ transcriptional profile to that of old adult normal controls shows upregulation of genes involved in late osteogenic commitment. Such is the case of ontology terms that include osteoblast differentiation, ossification, and chondrocyte differentiation (<xref ref-type="fig" rid="fig3">Figure 3C</xref>). In parallel, genes included in pathways related to cation homeostasis, particularly calcium, are downregulated (<xref ref-type="fig" rid="fig3">Figure 3D</xref>). This comparison is similar to that of young patients and normal middle-aged adult controls (<xref ref-type="fig" rid="fig3">Figure 3E</xref>).</p><p>Lipid homeostasis and transport pathways are downregulated in all comparisons between samples from young patients. Young HGPS samples show downregulation in pathways involving fat cell differentiation when compared to age-matched controls, in line with observed fat deposition defects in patients (<xref ref-type="bibr" rid="bib69">Revêchon et al., 2017</xref>; <xref ref-type="fig" rid="fig4">Figure 4A–C</xref>).</p><p>Gene ontology terms related to blood vessels show upregulation of blood vessel morphogenesis, but a decrease of blood vessel maturation when comparing samples from young patients to either age-matched or old controls (<xref ref-type="fig" rid="fig5">Figure 5A–C</xref>). This phenotype persists in comparisons between teen aged patients and their age-matched controls (<xref ref-type="fig" rid="fig5">Figure 5D</xref>). Further, in a possible contribution to the circulatory defects observed in HGPS patients, both young and teen-aged patient samples show a marked upregulation of genes in pathways related to muscle development and cardiac muscle differentiation and development when comparing both HGPS cohorts against adult controls (<xref ref-type="fig" rid="fig6">Figure 6A–C</xref>).</p></sec><sec id="s2-3"><title>Age stratification of young patients highlights differences in HGPS gene misregulation across childhood</title><p>To further refine our findings related to young age patients and the mesenchymal phenotypes observed, we stratified the young HGPS patients into two age groups: early infancy (0–3 years old) and children (4–7 years old), comparing these cohorts to age matched, middle age and old controls as before. The total numbers of genes up and down regulated between comparisons are described in <xref ref-type="table" rid="table2">Table 2</xref> and <xref ref-type="supplementary-material" rid="table2sdata1">Table 2—source data 1</xref>. In this analysis, about forty percent of genes upregulated in early infant patients when compared against their age matched controls are related to epigenetic modifications as described in the previous analysis (<xref ref-type="fig" rid="fig1">Figure 1</xref>). Specifically, the GO term ‘HDACs deacetylate histones’ shows the highest enrichment in this group. These same genes are represented in the comparison with the middle age-old adult control groups.</p><table-wrap id="table2" position="float"><label>Table 2.</label><caption><title>Number of up/down-regulated genes in young patient cohort comparisons.</title><p><supplementary-material id="table2sdata1"><label>Table 2—source data 1.</label><caption><title>Metascape outputs for gene ontology analysis.</title><p>Early and late childhood patient samples compared to healthy children, middle aged, and older adults.</p></caption><media mimetype="application" mime-subtype="zip" xlink:href="elife-81290-table2-data1-v2.zip"/></supplementary-material></p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="top">Comparisons</th><th align="left" valign="top">Upregulated genes</th><th align="left" valign="top">Downregulated genes</th></tr></thead><tbody><tr><td align="left" valign="top">Early Infant – Age matched</td><td align="char" char="." valign="top">113</td><td align="char" char="." valign="top">25</td></tr><tr><td align="left" valign="top">Early Infant – Middle aged adult</td><td align="char" char="." valign="top">540</td><td align="char" char="." valign="top">172</td></tr><tr><td align="left" valign="top">Early Infant – Old adult</td><td align="char" char="." valign="top">646</td><td align="char" char="." valign="top">388</td></tr><tr><td align="left" valign="top">Children - Age matched</td><td align="char" char="." valign="top">203</td><td align="char" char="." valign="top">102</td></tr><tr><td align="left" valign="top">Children - Middle aged adult</td><td align="char" char="." valign="top">173</td><td align="char" char="." valign="top">184</td></tr><tr><td align="left" valign="top">Children - Old adult</td><td align="char" char="." valign="top">305</td><td align="char" char="." valign="top">394</td></tr></tbody></table></table-wrap><p>In contrast, the comparison of patients aged 4–7 years to their age matched controls show an enrichment for ossification and calcium homeostasis. Out of the cohort of genes identified as downregulated in this comparison (102), about 10% are related to early chondrogenesis events. Among those, parathyroid hormone related protein (PTHLH), insulin like growth factor (IGF1), bone morphogenic protein receptor 1B (BMPR1B), and collagen 10a1 (COL10a1), are an integral part of early commitment and control necessary for the triggering of endochondral ossification (<xref ref-type="bibr" rid="bib6">Bradley and Drissi, 2010</xref>; <xref ref-type="bibr" rid="bib33">Green et al., 2015</xref>; <xref ref-type="bibr" rid="bib56">Maruyama et al., 2010</xref>). Genes related to ossification and calcium homeostasis were also identified as downregulated in this cohort. Further, upregulated genes in age-matched and adult comparisons include BMP4, and several genes related to WNT5a biology which play an important role in skeletal development (<xref ref-type="fig" rid="fig7">Figure 7A–C</xref>).</p><fig id="fig7" position="float"><label>Figure 7.</label><caption><title>Transcriptional missregulation in genes related to endochondral ossification.</title><p>(<bold>A</bold>) Heat map of RNA-seq transcriptome analysis for 25 selected genes related to endochondral ossification. The heat map shows per-gene z-score computed from batch effect corrected log2 read count values, genes in rows and 29 patient samples (progeria and young/adult/old control) organized in columns. Genes were hierarchically clustered based on Euclidean distance and average linkage. Blue lines separate young infants (0–3 y/o) from children (4–7 y/o) and older children (8–10 y/o). Genes related to WNT5a biology highlighted (red circle). (<bold>B</bold>) Abridged signaling pathway for WNT5a, highlighting the roles of the genes whose transcription is affected in young HGPS patients compared to their aged-matched controls. (<bold>C</bold>) BMP4 expression, also identified as significantly upregulated in the analysis of all HGPS patients (<xref ref-type="fig" rid="fig3">Figure 3</xref>) differs between Progeria (pink) and control (blue) samples. (* indicates p&lt;0.05 by Kruskal Wallis test; dotted lines within the violin plots indicate 25<sup>th</sup>, median, and 75<sup>th</sup> percentiles).</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig7-v2.tif"/></fig></sec><sec id="s2-4"><title>Genes of interest are impacted by chromatin compartment switches or abnormal lamina associated domains (LADs)</title><p>Chromosome conformation capture was performed on skin fibroblasts from parents of HGPS patients (Mother AG03257, Father HGADFN168), from 8-year-old male and female HGPS patients (HGADFN167 and AG11513), and from an age matched (8-year-old male) healthy control (GM08398) (<xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref>). Genome-wide contact maps for all of these cells show globally similar patterns of chromosome conformation, with the exception of a translocation between chr3 and chr11 in AG11513 cells (<xref ref-type="fig" rid="fig8">Figure 8A</xref>). At a whole chromosome folding level, we note that progeria fibroblasts show a decrease in telomere interactions and an apparent loss of ‘Rabl’ like structure (<xref ref-type="fig" rid="fig8">Figure 8B</xref>). This type of Rabl structure loss was previously observed after DNA damage in fibroblasts (<xref ref-type="bibr" rid="bib72">Sanders et al., 2020</xref>). We find that topologically associating domain (TAD) structure is preserved in Progeria fibroblasts, with even an increase in TAD boundary strength as compared to healthy parent controls (<xref ref-type="fig" rid="fig8">Figure 8C</xref>). A similar increase in TAD boundary strength was previously found in senescent and progerin-expressing human mesenchymal progenitor cells (<xref ref-type="bibr" rid="bib54">Liu et al., 2022</xref>). Increased TAD boundary strength was also previously observed in DNA damaged fibroblasts (<xref ref-type="bibr" rid="bib72">Sanders et al., 2020</xref>), suggesting that some of these features of genome structure may relate to the increased constitutive levels of DNA damage observed in these patient fibroblasts.</p><fig-group><fig id="fig8" position="float"><label>Figure 8.</label><caption><title>Changes in chromatin architecture in HGPS cells: translocations, compartment strength and identity, and correlation to genes of interest.</title><p>(<bold>A</bold>) 2.5 Mb Hi-C heatmaps for AG03257-P7 (Mother, WT), and HGPS patients (HGADFN167-P19 and AG11513-P7) Translocations between chromosomes appear as high interaction frequency regions (red) away from the diagonal. A translocation between chromosomes 3 and 11 is apparent in AG11513 cells (circle). (<bold>B</bold>) Log ratio of 2.5 Mb contact frequency in Progeria (167-P19) vs. healthy father (168-P16). Loss of telomere interactions is notable as blue patches in the corner of each chromosome. (<bold>C</bold>) TAD boundary strength boxplots calculated using the InsulationScore approach between early (left) and late (right) passage Progeria cells minus their respective controls. Boxes represent the upper and lower quartiles with the center line as the median. Upper whiskers extend 1.5×IQR beyond the upper quartile, and lower whiskers extend either 1.5×IQR below the lower quartile or to the end of the dataset. (<bold>D</bold>) Plots of the first eigenvector for a section of chromosome 12, obtained from principal component analysis (PC1) of 250 kb binned Hi-C data for control fibroblasts (Mother AG03257, Father HGADFN168) and HGPS fibroblasts (HGADFN167 and AG11513). Compartment identity remains predominantly unchanged (A compartment: Red, B compartment: Blue). (<bold>E</bold>) Graphs showing the A-A compartment interaction strength (red) and B-B compartment interaction strength (blue) within each chromosome for related father and child cell lines (HGADFN168, HGADFN167). Samples were collected a both early (left; P12) and late passages (middle; P19 for Progeria and P27 for father). Comparison between the two samples (right) shows that the HPGS cell line shows a marked decrease in A-A compartment interaction strength in late passages in the majority of chromosomes. (<bold>F</bold>) Eigen 1 values represent the compartment identity (same as plotted in D) for genes identified in this study as upregulated (left) or downregulated (right) in the 0–7 year-old age-matched comparison. While differences between groups are not significant overall (Kruskal-Wallis), a subset of downregulated genes appear to be changing conformation to a B compartment in progeria samples (box). Violin plots for the global distribution of values; median denoted by a thick dashed line, 25th and 75th percentiles highlighted as thin dashed lines. Percentages of genes in the B compartment are indicated in the box below downregulated gene graph. (<bold>G</bold>) Compartment identity for genes identified in this study as upregulated (left) or downregulated (right) in the 0–7 year-old HGPS samples compared to normal middle-aged controls. (<bold>H</bold>) Compartment identity for genes identified in this study as upregulated (left) or downregulated (right) in the 0–7 year-old HGPS samples compared to old-aged controls.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig8-v2.tif"/></fig><fig id="fig8s1" position="float" specific-use="child-fig"><label>Figure 8—figure supplement 1.</label><caption><title>Genes of interest vs LADS.</title><p>(<bold>A</bold>) The genomic regions for downregulated genes identified in our age comparisons were compiled with the LAD identity found in father and HGPS child fibroblasts (HGADFN168 and HGADFN167, respectively). Comparisons are presented as follows, from left to right: Young HGPS (0–7 years old) compared to middle-aged controls, young HGPS patients compared to old controls, teenaged HGPS compared to middle-aged controls and teenaged HGPS compared to old controls. Differences between al groups are significant (Kruskal-Wallis p&lt;0.001) Violin plots for the global distribution of values; median denoted by thick dashed line, 25th and 75th percentiles highlighted as thin dashed lines. (<bold>B</bold>) The genomic regions for up regulated genes identified in our age comparisons were compiled with the LAD identity found in father and HGPS child fibroblasts (HGADFN168 and HGADFN167, respectively). Comparisons are presented as follows, from left to right: Young HGPS (0–7 years old) compared to middle-aged controls, young HGPS patients compared to old controls, teenaged HGPS compared to middle-aged controls and teenaged HGPS compared to old controls. Differences between al groups are significant (Kruskal-Wallis p&lt;0.001) Violin plots for the global distribution of values; median denoted by thick dashed line, 25th and 75th percentiles highlighted as thin dashed lines. (<bold>C</bold>) LAD distribution along chromosome 1 and 21. LAD identity remains consistent among samples, with small regional changes in LAD definition in specific areas (highlighted- rectangle). The greatest difference among samples is the strength in LAD definition, as characterized by smaller positive and negative values. (<bold>D</bold>) The genome-wide distribution of LADs, as characterized by DamID-seq shows that normal fibroblast lines HGADFN168 (belonging to a father of an HGPS patient) and HFFc6 (human foreskin fibroblast), show a characteristic bimodal distribution in LAD intensity around positive (LAD) and negative (non-LAD) values. In contrast, LAD values for the HGPS cell line HGADFN167 distribute normally, around zero.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig8-figsupp1-v2.tif"/></fig></fig-group><p>Using principal component analysis of Hi-C data at 250 kb-resolution, we classified genomic regions into open euchromatin (A) or closed heterochromatin (B) spatial compartments according to positive and negative values of the first eigenvector, respectively. Since accelerated senescence has been previously observed in progeria fibroblasts (<xref ref-type="bibr" rid="bib7">Bridger and Kill, 2004</xref>; <xref ref-type="bibr" rid="bib79">Wheaton et al., 2017</xref>), we performed compartment analysis on cells belonging to a father-child pair, at early and late passages. Samples were collected for the HGADFN168 cells (Father) at passages 12 and 27, and for the HGADFN167 (Child) at passages 12 and 19. Our results show that in the parent fibroblasts there are small changes in compartment strength (the degree of preference for interactions within the same compartment vs. between different compartments). In contrast, there is a predominant loss of A compartment strength in the late passage HGPS cells (<xref ref-type="fig" rid="fig8">Figure 8E</xref>). Interestingly, although the compartmentalization strength appears to be altered, the genome-wide compartment identity remains consistent among cohorts, with small changes in compartment identity appearing sporadically (<xref ref-type="fig" rid="fig8">Figure 8D</xref>). The loss of compartment strength at later passages in Progeria cells is consistent with previous observations, though this more deeply sequenced, and less noisy dataset shows that compartments are more preserved in Progeria cells than previously observed (<xref ref-type="bibr" rid="bib59">McCord et al., 2013</xref>).</p><p>To test whether the up or downregulation of genes identified through this study relates to compartment switching, we evaluated the compartment identity strength of all up- or down-regulated genes, based on their genomic coordinates, in the healthy and patient datasets. We found that genes that are upregulated in HGPS tend to be located in the A compartment in both HGPS and WT fibroblast samples, suggesting that many expression increases do not require chromosome compartment shifts (<xref ref-type="fig" rid="fig8">Figure 8F–H</xref>). In contrast, a subset of the genes that are downregulated in the 0–7 HGPS fibroblasts vs. normal age- matched or adult fibroblasts also shift toward the B compartment in HGPS samples compared to healthy adults. (<xref ref-type="fig" rid="fig8">Figure 8F–H</xref>).</p><p>To test whether the up or downregulation of genes identified through this study relates to abnormal distribution of lamin associated domains, we compiled the genomic coordinates of these genes with published Lamin ChIP-seq and DamID-seq data (<xref ref-type="bibr" rid="bib16">Dekker et al., 2017</xref>; <xref ref-type="bibr" rid="bib59">McCord et al., 2013</xref>). We observe that differences between all groups are significant, with HGPS Lamin A association values markedly higher than their control counterparts (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1A and B</xref>, Kruskal-Wallis p&lt;0.001). However, we found that this shift in Lamin association is true throughout all genomic regions, with an overall dampening of the lamin association signal in HGPS patients (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1C</xref>) and small regions switching from associated to dissociated from the nuclear lamina. Comparing normal fibroblast cells HGADFN168 (belonging to the father of an HGPS patient) and HFFc6 (human foreskin fibroblast), we observe that both show a characteristic bimodal distribution in LAD intensity around markedly positive (LAD) and negative (non-LAD) values (log2 Lamin/input). In contrast, LAD values for the HGPS fibroblasts HGADFN167 show a normal distribution around zero: the intensity of both types of association is reduced in HGPS cells, consistent with an overall misregulated interaction between chromosomes and the nuclear lamina (<xref ref-type="fig" rid="fig8s1">Figure 8—figure supplement 1D</xref>).</p><p>Certain key genes of interest related to osteogenesis and chondrogenic proliferation and identified as differentially regulated by transcriptomics show notable concordant alterations in compartment identity or lamina association. For example, bone morphogenic protein 4 (BMP4), which is upregulated in Progeria (<xref ref-type="fig" rid="fig7">Figure 7C</xref>), also shows a marked shift toward the A compartment in patient fibroblasts compared to both adult and age matched WT fibroblasts (<xref ref-type="fig" rid="fig9">Figure 9</xref>). In turn, Frizzled-4 (FZD4), which is upregulated in HGPS and involved in skeletal development, does not shift compartments but shows an erosion of Lamin association (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>). Similarly, the gene that encodes parathyroid hormone-like hormone (PTHLH), which is downregulated in HGPS, is in a conserved A compartment in both healthy and HGPS cells but shows an increase in Lamin association in patient cells (<xref ref-type="fig" rid="fig9s1">Figure 9—figure supplement 1</xref>). Consistent with the observation that compartment shifts were more likely to be found alongside gene downregulation, we also identified a set of key genes in the mesenchymal lineage that were both downregulated and shifted toward the B compartment in HGPS (<xref ref-type="fig" rid="fig9s2">Figure 9—figure supplement 2</xref>).</p><fig-group><fig id="fig9" position="float"><label>Figure 9.</label><caption><title>40 kb resolution heatmaps for the parental and HGPS fibroblasts around the BMP4 gene (highlight: blue), aligned to their associated compartment and LAD tracks.</title><p>The gene is located in a region that shifts toward the A compartment (red) in HGPS compared to WT parent and healthy child controls.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig9-v2.tif"/></fig><fig id="fig9s1" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 1.</label><caption><title>40 kb resolution Hi-C contact maps for the parental and HGPS cell lines, aligned with A/B compartment tracks for parental, healthy child, and HGPS cell lines.</title><p>The data is centered on FZD4 (le) and PTHLH (right), as shown in blue highlights. Both genes localize to the A compartment (red, positive values) even though FZD4 is upregulated in Progeria and PTHLH is downregulated (see <xref ref-type="fig" rid="fig7">Figure 7</xref>). FZD4 shows erosion of LAD domain (yellow/blue track) in HGPS while PTHLH shows a gain of Lamina contacts in HGPS.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig9-figsupp1-v2.tif"/></fig><fig id="fig9s2" position="float" specific-use="child-fig"><label>Figure 9—figure supplement 2.</label><caption><title>A/B compartment tracks for parental, healthy child, and HGPS cell lines and Lamin A association tracks for healthy father and HGPS patient centered on genes detected as downregulated in Progeria compared to healthy children.</title><p>Compartments shift toward negative (more B-associated) values at the locations of these genes, shown in blue highlights. Functional categories relevant to the genes (as categorized in <xref ref-type="fig" rid="fig1">Figures 1</xref>—<xref ref-type="fig" rid="fig6">6</xref>) are listed below each gene.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig9-figsupp2-v2.tif"/></fig></fig-group></sec></sec><sec id="s3" sec-type="discussion"><title>Discussion</title><p>In this study, we present a comprehensive analysis of the transcriptome of HPGS patient derived fibroblasts, stratified by age, compared to their age-matched controls. Since progeria patients present with accelerated aging, we also compared this data to that derived from middle-aged and old adults. Strikingly, HPGS expression profiles do not phenocopy gene ontology analysis from either set of adult controls, suggesting an altered aging-like paradigm.</p><p>Given the critical role that Lamin A plays in nuclear structure, formation of heterochromatin, and subsequent gene silencing (<xref ref-type="bibr" rid="bib48">Lammerding et al., 2004</xref>; <xref ref-type="bibr" rid="bib51">Leemans et al., 2019</xref>), it is not surprising that one of the main biological processes affected in our study, as per gene ontology analysis, is DNA maintenance and epigenetics. Upregulation of genes in the HDAC family is the largest discriminator between Progeria and age-matched normal controls in the 0- to 3-year-old cohort and 4- to 7-year-old age groups, and this upregulation persists in comparisons with the adult controls. Our data suggests an upregulation of genes belonging to ontology terms such as negative epigenetic regulation of genes, chromatin silencing, DNA repair, double strand DNA repair and DNA recombination across all age comparison with young patients. Overexpression of these genes are a potential overcompensation mechanism for defects found in DNA repair (<xref ref-type="bibr" rid="bib1">Aguado et al., 2019</xref>; <xref ref-type="bibr" rid="bib30">Gonzalo and Kreienkamp, 2015</xref>; <xref ref-type="bibr" rid="bib43">Komari et al., 2020</xref>; Reviewed by <xref ref-type="bibr" rid="bib61">Misteli and Scaffidi, 2005</xref>). In older HGPS samples, downregulation of genes related to histone methylation, histone modification, chromatin modifying enzymes, and DNA recombination was also observed.</p><p>Concomitant with changes in gene expression of epigenetic factors, Progeria fibroblasts show alterations in chromosome structure, as has been previously observed (<xref ref-type="bibr" rid="bib59">McCord et al., 2013</xref>). The increased resolution and clarity of Hi-C data presented here enables us to describe these alterations more clearly. Spatial compartmentalization is weakened in Progeria patients with increasing passages consistent with microscopically observed loss of heterochromatin (<xref ref-type="bibr" rid="bib28">Goldman et al., 2004</xref>). Unlike compartments, topologically associating domain (TAD) boundaries are preserved during in Progeria cells, even at higher passages. When we compare gene expression changes to chromosome structure changes, we observe that many genes consistently upregulated across Progeria patients are in the open, A compartment across all Hi-C samples, suggesting that these gene expression alterations are not associated with dramatic chromosome structural change. Downregulated genes are more likely to exhibit switching into the B compartment in Progeria patients. We find that certain genes relevant to the mesenchymal lineage show gene expression changes that are concordant with compartment switches and lamin association changes. It is possible that these changes are more directly influenced by mutant lamin and lead to downstream effects on genes without observed chromosome structure changes.</p><sec id="s3-1"><title>A compromised transcriptional landscape, related to developmental milestones, points towards a compromised mesenchymal stem cell niche</title><p>We further describe up and down regulated biological function clusters that could play a detrimental role in bone, fat, joint and vascular homeostasis. It has been proposed that progerin accumulation in the nucleus results in a defect in the mesenchymal stem cell lineage which gives rise to osteoblasts, chondrocytes, adipocytes, pericytes, and myocytes (Reviewed by <xref ref-type="bibr" rid="bib3">Andrzejewska et al., 2019</xref>). Overall, our results are in concordance with previous reports of transcriptional misregulation in mesenchymal lineages (<xref ref-type="bibr" rid="bib14">Csoka et al., 2004</xref>), but the age group comparisons we present here further refine these observations to a temporal effect on lineage commitment.</p><p>iPSC models in which HGPS fibroblasts were reprogrammed to stem cells, and further differentiated into mesenchymal stem cells lineages were characterized by nuclear dysmorphia and increased DNA damage, but resulted in confounding results on differentiation, showing either limited differentiation potential, or no significant changes (<xref ref-type="bibr" rid="bib12">Crasto and Di Pasquale, 2018</xref>; <xref ref-type="bibr" rid="bib81">Xiong et al., 2013</xref>; <xref ref-type="bibr" rid="bib83">Zhang et al., 2011</xref>). Interestingly, the most common finding in HGPS-derived iPSCs further differentiated into other lineages is premature senescence and the presence of progerin and misshapen nuclei (Reviewed by <xref ref-type="bibr" rid="bib55">Lo Cicero and Nissan, 2015</xref>). In a more direct approach, overexpression of progerin in umbilical cord derived MSCs and other MSC systems resulted in a reduced capacity of differentiation into chondrogenic, osteogenic and adipogenic capacity in vitro (<xref ref-type="bibr" rid="bib57">Mateos et al., 2013</xref>) and deficient proliferation and migration (<xref ref-type="bibr" rid="bib66">Pacheco et al., 2014</xref>). In the context of these collective findings, our age-stratified gene expression comparisons in fibroblasts may shed light on whether this abnormal cell fate regulation occurs predominantly in a particular lineage.</p></sec><sec id="s3-2"><title>Failed arrest of chondrocyte hypertrophy as a potential mechanism of MSC depletion in HGPS</title><p>Transcriptional upregulation of several members of the WNT5a signaling cascade and downregulation of expression of PTHLH, in early age comparisons described in this study, point to an essential defect in early endochondral ossification control and osteogenesis. Specifically, WNT signaling has been previously implicated as a connection between progeria-like syndromes and a defective deposition of extra cellular matrix, essential in bone development (<xref ref-type="bibr" rid="bib2">Andrade et al., 2017</xref>; <xref ref-type="bibr" rid="bib33">Green et al., 2015</xref>; <xref ref-type="bibr" rid="bib35">Hernandez et al., 2010</xref>). Not unlike the phenotypes observed in HGPS patients, bone defects are also present in murine models for HGPS, with young mice (4-week-old) showing decreased trabecular thickness and number, bone volume and decreased mineral density (<xref ref-type="bibr" rid="bib35">Hernandez et al., 2010</xref>). Not surprisingly, murine pre-osteoblasts forced to express mouse progerin failed to mineralize and show decreased levels of Runx2 expression and alkaline phosphatase upon osteoblastic induction (<xref ref-type="bibr" rid="bib76">Tsukune et al., 2019</xref>). Further, Lamin A knockdown inhibits osteoblast proliferation and impairs osteoblast differentiation in an MSC in vitro differentiation model (<xref ref-type="bibr" rid="bib67">Rauner et al., 2009</xref>).</p><p>Unlike other MSC fates, like adipogenesis, which occurs downstream of a positive energy intake all through life, bone formation occurs in a carefully orchestrated manner, at specific timepoints during development and early life. Secondary endochondral ossification that occurs in long bones like the humerus and femur, initiate in early childhood, activate intermittently, and finalize with the fusion of the growth plate during the teenage years (<xref ref-type="bibr" rid="bib20">Diméglio et al., 2005</xref>; <xref ref-type="bibr" rid="bib80">Xie and Chagin, 2021</xref>; <xref ref-type="bibr" rid="bib87">Zoetis et al., 2003</xref>). This process is tightly regulated by several signaling networks aimed at balancing longitudinal growth of the bone with maintenance of precursor cells, like MSCs and quiescent chondrocytes. The transcriptional repression of PTHLH and upregulation of WNT5a in this niche would result in early depletion of the latter, as cells continue down a pathway of chondrocyte proliferation and hypertrophy unimpeded (<xref ref-type="bibr" rid="bib6">Bradley and Drissi, 2010</xref>; <xref ref-type="bibr" rid="bib64">Olsen et al., 2000</xref>; <xref ref-type="bibr" rid="bib77">Usami et al., 2016</xref>). The deficit in clavicular development in HPGS patients could provide some insight as to the spatiotemporal consequences of MSC/chondrocyte pool depletion. The clavicle is unique because while it is the first bone to start ossification during the embryonic period (<xref ref-type="bibr" rid="bib63">Ogata and Uhthoff, 1990</xref>), it is the last to complete the process. In early events, around the fifth week of gestation, the two primary ossification centers, formed from mesenchymal tissues, fuse to form the middle of the clavicle. The complete ossification of the clavicular epiphysis occurs via endochondral ossification during the teenage years, with medial ossification beginning at the onset of puberty (<xref ref-type="bibr" rid="bib24">Ferguson and Scott, 2016</xref>; <xref ref-type="bibr" rid="bib49">Langley, 2016</xref>). In turn, bone deposition at the terminal ossification center, must occur in adolescents between 11 and 16 years of age, for the process to successfully proceed to epiphyseal plate ossification in early adulthood. (<xref ref-type="bibr" rid="bib73">Schulz et al., 2008</xref>). Taken together, our observations point towards a ‘fail to arrest’ phenotype that results in over-commitment towards the hypertrophic chondrocyte lineage in very young HGPS patients. We hypothesize that this results in a premature depletion of the chondro-osteoprogenitor pool and, at later stages, of the bone marrow-derived mesenchymal stem cells that feed into this niche later in life result in the incomplete endochondral ossification of the claviculae of HGPS patients (<xref ref-type="video" rid="video1">Video 1</xref>).</p><media mimetype="video" mime-subtype="mp4" xlink:href="elife-81290-video1.mp4" id="video1"><label>Video 1.</label><caption><title>A visual explanation of ideas presented in the Discussion, hypotheses derived from transcriptomics results.</title></caption></media></sec><sec id="s3-3"><title>Deficient repair responses exacerbate the depletion of tissue resident MSC pools</title><p>A secondary function of tissue resident MSCs is to aid in repair during wounding and disease.</p><p>Our data shows that dermal fibroblasts derived from HPGS patients present with abnormal repair, including downregulated signatures of wound healing, hemostasis, and BMP signaling. These observations recapitulate previous reports of HGPS patient-derived skin precursors, which can differentiate intro fibroblasts and smooth muscle cells (smooth muscle alpha actin positive – myofibroblasts). In the precursor stage, these cells express low levels of progerin in vivo and in vitro, but differentiation into the lineages increases progerin expression and deposition in the nucleus (<xref ref-type="bibr" rid="bib78">Wenzel et al., 2012</xref>). In concordance with our findings, a progeria murine model, deficient in the downstream processing of lamin A, shows abnormal skin wound repair, with prolonged time to wound closure, poor vasculogenic signaling and angiogenesis, which includes a limited mobilization of bone-marrow derived progenitor cells (<xref ref-type="bibr" rid="bib8">Butala et al., 2012</xref>). Related to this phenotype, the LMNAΔ9 murine progeria model for HPGS show a significant decrease in postnatal fibroblast proliferation, with accelerated senescence levels in cell lines derived from kidney, lung, skin, and skeletal muscle (<xref ref-type="bibr" rid="bib35">Hernandez et al., 2010</xref>). Further, a decreased epidermal population of adult stem cells was observed in another murine model of HGPS (<xref ref-type="bibr" rid="bib70">Rosengardten et al., 2011</xref>), which are also deficient for skin wound repair.</p><p>Overall, growth, development, and maintaining homeostasis place a considerable burden on the mesenchymal stem cell pool and its many lineages. Under a paradigm of biology of priority during development the organism’s structural integrity in the shape of bones and joints, the homeostasis of blood microvessels – regulated by pericytes – should take precedence to fat deposition (<xref ref-type="fig" rid="fig10">Figure 10A</xref>).</p><fig id="fig10" position="float"><label>Figure 10.</label><caption><title>Discussion model.</title><p>HGPS affects differentiation commitment and subsequent biology of priority during early development, which results in premature depletion of MSC pools.</p></caption><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-fig10-v2.tif"/></fig><p>We propose that these defects in repair in Progeria patients strain the mesenchymal stem cell pools from which repair reactive stroma originates, which have been characterized as both pools of CD44/CD99-positive cells in glandular tissues and as pluripotent cells located at the pericyte position (<xref ref-type="bibr" rid="bib13">Crisan et al., 2008</xref>; <xref ref-type="bibr" rid="bib40">Kim et al., 2014</xref>). Interestingly, it has been reported that normal fibroblast cell lines contain a subset of pluripotent MSCs, indistinguishable from those derived from the bone marrow (<xref ref-type="bibr" rid="bib17">Denu et al., 2016</xref>) and it is established that normal MSCs lose proliferative and differentiation potential within a few passages when cultured in vitro. This phenomenon has been correlated with a defect in lamin A maturation that leads to cellular senescence (<xref ref-type="bibr" rid="bib5">Bellotti et al., 2016</xref>), which is similar to the terminal differentiation into wound-repair-myofibroblasts resulting from the TGF-beta induction of prostate resident MSCs (<xref ref-type="bibr" rid="bib40">Kim et al., 2014</xref>). HPGS fibroblasts experience an increased rate in apoptosis, with subsequent cell divisions, concomitant with mutant Lamin A accumulation (<xref ref-type="bibr" rid="bib7">Bridger and Kill, 2004</xref>), and chronic DNA damage that lead to premature senescence (<xref ref-type="bibr" rid="bib79">Wheaton et al., 2017</xref>),which could be indirect evidence of early depletion of the MSC pool in these cell lines. (<xref ref-type="fig" rid="fig10">Figure 10B</xref>).</p><p>Related to later differentiation events, the depletion of microvasculature resident MSCs occurring as a result of chronic, deficient wound repair would carry a severe impact to adipogenesis. Cells at the pericyte position have been characterized as the primary source for adipocytes in vivo (<xref ref-type="bibr" rid="bib75">Traktuev et al., 2008</xref>; <xref ref-type="bibr" rid="bib82">Zannettino et al., 2008</xref>). These cells, which are CD44, CD90 double positive, phenocopy the pluripotency of tissue resident mesenchymal stem cells, and are able to differentiate into repair-like myofibroblasts expressing smooth muscle alpha actin (<xref ref-type="bibr" rid="bib60">Merfeld-Clauss et al., 2017</xref>). Coupled with a preadipocyte depletion phenotype, lipodystrophy in HGPS has also been experimentally induced by the introduction of progerin expression into a subset of pre adipogenic cells in mice, which led to fibrosis, senescence, and macrophage infiltration, with the ultimate result of white fat depletion (<xref ref-type="bibr" rid="bib69">Revêchon et al., 2017</xref>).</p></sec><sec id="s3-4"><title>The fibroblast as a sentinel of general mesenchymal lineage health</title><p>The criticism can be made that it is a stretch to make hypotheses about different mesenchymal stem cell pools based only on gene expression from dermal fibroblasts. This is indeed a limitation that must be considered, but primary samples of other mesenchymal lineage tissues from HGPS patients are not available, and there is evidence of interplay between fibroblasts and the MSC lineage. After birth, the bone marrow mesenchymal stem cell niche is in close synergy with pools of fibroblasts (<xref ref-type="bibr" rid="bib50">LeBleu and Neilson, 2020</xref>; <xref ref-type="bibr" rid="bib74">Soundararajan and Kannan, 2018</xref>), tissue resident mesenchymal stem cells (<xref ref-type="bibr" rid="bib22">El Agha et al., 2017</xref>) and pericytes (<xref ref-type="bibr" rid="bib47">Lamagna and Bergers, 2006</xref>). Since these cell pools are in flux, and can compensate for each other under duress (<xref ref-type="bibr" rid="bib19">Di Carlo and Peduto, 2018</xref>; <xref ref-type="bibr" rid="bib21">Direkze et al., 2004</xref>; <xref ref-type="bibr" rid="bib65">Ozerdem et al., 2005</xref>; <xref ref-type="bibr" rid="bib71">San Martin et al., 2014</xref>), comparing the global transcriptional status of fibroblasts between a patient cohort and its aged-matched controls can provide an insight into potential systemic deficits and compensatory mechanisms at play.</p></sec><sec id="s3-5"><title>Ideas and speculation</title><p>Overall, the cohorts of biological processes that we observe to be misregulated across different age groups of Progeria patients lead us to speculate the impact of this misregulation across a series of events in development, which will warrant further investigation:</p><list list-type="order"><list-item><p>Biology of priority: the formation of bone ‘fires’ at specific times. These events are ‘non-negotiable’, potentially taking precedence over other concomitant MSC fates. Deficits in endochondral ossification can condition the system to draw from pericyte and tissue resident MSCs in an attempt to compensate.</p></list-item><list-item><p>The loss of bone fusion and regression of bone length observed in teenaged HGPS patients is an indirect result of deficits in arrest of chondrogenesis proliferation, that occurred in early childhood. These deficits may result in depletion of MSC pools, both in the bone marrow and in tissues</p></list-item><list-item><p>Depletion of the pericyte niche is exacerbated by a chronic, incompetent, wound repair response. Ultimately, this depletion will result in loss of microvasculature integrity and subsequent vascular events observed in HGPS, such as vascular stiffness and atherosclerosis.</p></list-item><list-item><p>In adipose tissue, the activation of MSCs located at the pericyte niche for addressing deficient wound repair response or osteogenesis, could lead to a deficient differentiation into adipocytes</p></list-item><list-item><p>Elaborating on proposed MSC interventions (<xref ref-type="bibr" rid="bib39">Infante and Rodríguez, 2021</xref>) and current gene editing efforts (<xref ref-type="bibr" rid="bib41">Koblan et al., 2021</xref>), targeting the bone marrow niche in young patients could rescue the later HGPS phenotypes.</p></list-item></list></sec><sec id="s3-6"><title>Conclusion</title><p>Our comprehensive analysis of previously published and newly generated RNA-seq datasets for Progeria fibroblast cells enabled careful age-stratified comparisons. Comparing young children and teenagers with Progeria to age-matched controls, middle-aged, and elderly adults, we find misregulated genes which suggest important defects in cell and tissue repair biology, epigenetics, metabolism (calcium, lipids), and other functions important to the mesenchymal cell lineage. Our comparisons show altered regulation of chondrocyte commitment genes in the fibroblasts of Progeria patients who are at the age of postnatal ossification compared to typically developing age-matched controls. Interestingly, the Progeria gene expression patterns are distinct from older adult fibroblast expression patterns, emphasizing that this disease does not simply mimic normal aging. While genome spatial compartmentalization in these patients is overall weakened, much of the gene misregulation occurs in regions that do not change their compartment status or lamin association. However, a few key misregulated genes in the osteogenic and adipogenic lineage show a clear concordant switch in spatial compartmentalization or lamin association, suggesting that some alterations in these pathways may result directly from the influence of progerin on chromosome structure.</p></sec></sec><sec id="s4" sec-type="materials|methods"><title>Materials and methods</title><table-wrap id="keyresource" position="anchor"><label>Key resources table</label><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Reagent type (species) or resource</th><th align="left" valign="bottom">Designation</th><th align="left" valign="bottom">Source or reference</th><th align="left" valign="bottom">Identifiers</th><th align="left" valign="bottom">Additional information</th></tr></thead><tbody><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG01178</td><td align="left" valign="bottom">Male 20 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG03198</td><td align="left" valign="bottom">Female 10 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG06917</td><td align="left" valign="bottom">Male 3 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG07493</td><td align="left" valign="bottom">Female 2 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG08466</td><td align="left" valign="bottom">Female 8 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG10578</td><td align="left" valign="bottom">Male 17 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG10677</td><td align="left" valign="bottom">Male 4 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG11572</td><td align="left" valign="bottom">Female 2 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">GM01178</td><td align="left" valign="bottom">Male 20 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">GM01972</td><td align="left" valign="bottom">Female 14 y/o</td></tr><tr><td align="left" valign="bottom">Biological sample (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">Purified RNA</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG11513</td><td align="left" valign="bottom">Female 8 y/o</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HGPS human primary dermal fibroblast</td><td align="left" valign="bottom">Progeria Research <break/>Foundation (PRF) <break/>Cell and Tissue Bank</td><td align="left" valign="bottom">HGADFN167</td><td align="left" valign="bottom">8-year-old male progeria patient</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">WT human primary dermal fibroblast</td><td align="left" valign="bottom">Progeria Research <break/>Foundation (PRF) <break/>Cell and Tissue Bank</td><td align="left" valign="bottom">HGADFN168</td><td align="left" valign="bottom">Father of progeria patient</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">HGPS human primary dermal fibroblast</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG11513</td><td align="left" valign="bottom">8-year-old female progeria patient</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">WT human primary dermal fibroblast</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">AG03257</td><td align="left" valign="bottom">Mother of progeria patient</td></tr><tr><td align="left" valign="bottom">Cell line (<italic>Homo sapiens</italic>)</td><td align="left" valign="bottom">WT human primary dermal fibroblast</td><td align="left" valign="bottom">Coriell Institute</td><td align="left" valign="bottom">GM08398</td><td align="left" valign="bottom">8-year-old male healthy child</td></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">HindIII</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">R0104L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">DpnII</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">R0543L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">T4 DNA Ligase</td><td align="left" valign="bottom">Invitrogen</td><td align="char" char="." valign="bottom">15224041</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">DNA Polymerase I Klenow Fragment</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">M0210L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">T4 DNA Polymerase</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">M0203L</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Peptide, recombinant protein</td><td align="left" valign="bottom">Biotin-dATP</td><td align="left" valign="bottom">Invitrogen</td><td align="char" char="." valign="bottom">19524016</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">Arima-HiC +Kit</td><td align="left" valign="bottom">Arima Genomics</td><td align="left" valign="bottom">Mammalian Cell Lines Protocol (A160134 v01)</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBNext Ultra II kit</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">E7645S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBNext Multiplex Oligos for Illumina (Index Primers Set 4)</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">E7730S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Commercial assay or kit</td><td align="left" valign="bottom">NEBNext Multiplex Oligos for Illumina (Index Primers Set 1)</td><td align="left" valign="bottom">New England Biolabs</td><td align="left" valign="bottom">E7335S</td><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">BBDuk</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/kbaseapps/BBTools">https://github.com/kbaseapps/BBTools</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_016968">SCR_016968</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">STAR aligner</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">https://github.com/alexdobin/STAR</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_004463">SCR_004463</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">HTSeq-Counts</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/simon-anders/htseq">https://github.com/simon-anders/htseq</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom">RRID:<ext-link ext-link-type="uri" xlink:href="https://identifiers.org/RRID/RRID:SCR_011867">SCR_011867</ext-link></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">DESeq2</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link></td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">cMapping</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/dekkerlab/cMapping">https://github.com/dekkerlab/cMapping</ext-link> (<xref ref-type="bibr" rid="bib44">Lajoie et al., 2015</xref>; <xref ref-type="bibr" rid="bib45">Lajoie and Oomen, 2015</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">v1.0.6; Bryan Lajoie<break/></td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">cWorld-dekker</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/dekkerlab/cworld-dekker">https://github.com/dekkerlab/cworld-dekker</ext-link> (<xref ref-type="bibr" rid="bib46">Lajoie and Venev, 2019</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom">v0.41.1; Bryan Lajoie</td></tr><tr><td align="left" valign="bottom">Software, algorithm</td><td align="left" valign="bottom">ComBat-seq</td><td align="left" valign="bottom"><ext-link ext-link-type="uri" xlink:href="https://github.com/zhangyuqing/ComBat-seq">https://github.com/zhangyuqing/ComBat-seq</ext-link> (<xref ref-type="bibr" rid="bib84">Zhang et al., 2020a</xref>; <xref ref-type="bibr" rid="bib85">Zhang et al., 2020b</xref>)</td><td align="left" valign="bottom"/><td align="left" valign="bottom"/></tr></tbody></table></table-wrap><sec id="s4-1"><title>RNA-seq</title><p>Ten micrograms of purified RNA from several progeria cell samples were acquired from the Coriell Institute (Camden, NJ) as follows: AG06917 (HGPS. Male 3 y/o), AG10578 (HGPS. Male 17 y/o), AG11572 (HGPS. Female 2 y/o), AG10677 (HGPS. Male 4 y/o), AG08466 (HGPS. Female 8 y/o), AG03198 (HGPS. Female 10 y/o), AG07493 (HGPS. Female 2 y/o), AG01178 (HGPS. Male 20 y/o), AG11513 (HGPS. Female 8 y/o), GM01972 (HGPS. Female 14 y/o), GM01178 (HGPS. Male 20 y/o). After internal quality control upon receipt, RNA-seq library construction and sequencing of two technical replicates was carried out by Genewiz (South Plainfield, NJ). Further, previously published RNA-seq datasets from HPGS fibroblasts and normal controls were included in the study (<xref ref-type="table" rid="app1table1 app1table2 app1table3">Appendix 1—tables 1–3</xref>; <xref ref-type="bibr" rid="bib25">Fleischer et al., 2018</xref>; <xref ref-type="bibr" rid="bib37">Ikegami et al., 2020</xref>; <xref ref-type="bibr" rid="bib42">Köhler et al., 2020</xref>; <xref ref-type="bibr" rid="bib58">Mateos et al., 2018</xref>).</p></sec><sec id="s4-2"><title>RNA-seq data processing</title><p>The fastq reads were first processed with BBDuk tool (<ext-link ext-link-type="uri" xlink:href="https://github.com/kbaseapps/BBTools">https://github.com/kbaseapps/BBTools</ext-link>), performing adapter trimming with parameters “ktrim = r k=23 mink = 11 hdist = 1”. Adapter trimmed reads were processed for quality trimming using the BBDuk tool to discard reads with quality score lower than 28 (parameters “qtrim = r trimq = 28”). Following the adapter and quality trimming steps, the reads were aligned to the reference genome hg19 using STAR aligner (<ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">https://github.com/alexdobin/STAR</ext-link>) with both ‘<monospace>--outFilterScoreMinOverLread</monospace>’ and ‘<monospace> --outFilterMatchNminOverLread</monospace>’ parameters set to 0.2. Finally, the mapped reads were sorted based on genomic coordinates and feature count was performed with HTSeq-Counts (<ext-link ext-link-type="uri" xlink:href="https://github.com/simon-anders/htseq">https://github.com/simon-anders/htseq</ext-link>).</p></sec><sec id="s4-3"><title>Batch effect removal</title><p>Since the RNA-seq files used in this study were generated in different laboratories, using different technologies, the raw gene counts produced by HTSeq-Counts suffer from batch effect. To mitigate that issue, the raw counts are batch effect adjusted using the ComBat-seq tool (<ext-link ext-link-type="uri" xlink:href="https://github.com/zhangyuqing/ComBat-seq">https://github.com/zhangyuqing/ComBat-seq</ext-link>). For this purpose, files from the same laboratory are assigned the same batch number. In addition, the sex and status of the samples are provided as the biological covariates to the ComBat-seq tool to preserve that signal in the adjusted data.</p></sec><sec id="s4-4"><title>Differential expression analysis</title><p>Differential gene expression analysis was performed between different groups of diseased and healthy samples using DESeq2 (<ext-link ext-link-type="uri" xlink:href="https://bioconductor.org/packages/release/bioc/html/DESeq2.html">https://bioconductor.org/packages/release/bioc/html/DESeq2.html</ext-link>) tool. HGPS samples from Young (0–7 y/o) or teenage (13+y/o) patients were compared to age matched (AM), middle aged (M), and old (O) control samples (<xref ref-type="supplementary-material" rid="table1sdata1">Table 1—source data 1</xref>). Further, to correlate gene expression profiles with known patient survival statistics, comparisons were further refined by stratifying early infancy progeria patients (0–3 years old) and older children (4–7 years old), comparing those populations to age matched, middle aged and old control samples, as before (<xref ref-type="supplementary-material" rid="table2sdata1">Table 2—source data 1</xref>).</p></sec><sec id="s4-5"><title>Gene ontology analysis</title><p>Genes defined as up/down regulated for each of the age group comparisons, were considered for gene ontology analysis based on an FDR adjusted p-value cutoff of 0.001. These gene lists, in turn, were then analyzed using Metascape (<xref ref-type="bibr" rid="bib86">Zhou et al., 2019</xref>). Metascape output files were manually clustered into gene ontology themes, observed throughout the analysis. Gene lists derived from this manual clustering were then visualized via heatmaps to facilitate comparisons among age groups.</p></sec><sec id="s4-6"><title>Gene expression heatmap plotting</title><p>To plot expression of specific genes across different samples as a heatmap, the batch adjusted counts for all the genes for each sample were log2 normalized with a pseudo count of 1. The expression of specific genes across specific samples was then extracted and Z-score normalization was performed for each of the genes. Finally, the Z-score normalized values were plotted using the Seaborn python package as a heatmap. (<ext-link ext-link-type="uri" xlink:href="https://seaborn.pydata.org/">https://seaborn.pydata.org/</ext-link>).</p></sec><sec id="s4-7"><title>DamID-seq data processing</title><p>All the DamID-seq data was processed as previously reported (<xref ref-type="bibr" rid="bib51">Leemans et al., 2019</xref>), with modifications in the trimming step. Briefly, the bwa mem (<ext-link ext-link-type="uri" xlink:href="https://github.com/lh3/bwa">https://github.com/lh3/bwa</ext-link>, <xref ref-type="bibr" rid="bib53">Li, 2022</xref>) tool was used to map gDNA reads starting with GATC to a combination of hg19 reference genome with a ribosomal model. For further processing, only the mapped reads having a mapping quality of at least 10 were considered as GATC fragments. Next, the reads were combined into the bins of 40 kb resolution depending on the middle of the GATC fragments and then scaled to 1 M reads. For normalization, log2-ratio of the scaled target over the scaled Dam-only bins was calculated with a pseudo count of 1.</p></sec><sec id="s4-8"><title>Cell culture</title><p>Human primary dermal fibroblast cell lines were obtained from The Progeria Research Foundation (PRF) Cell and Tissue Bank (HGPS: HGADFN167 and healthy adult: HGADFN168). Dermal fibroblasts (HGPS: AG11513, healthy adult: AG03257, and healthy child GM08398) were purchased from Coriell Institute (Camden, NJ). Cells were grown in DMEM (Gibco) supplemented with 15% FBS (Corning), 1% Pen-strep (Gibco), and 1% L-glutamine (Gibco). Cells were passaged at a density of 80%.</p></sec><sec id="s4-9"><title>Chromosome conformation capture (Hi-C)</title><p>Hi-C experiments were performed according to standard protocols (<xref ref-type="bibr" rid="bib29">Golloshi et al., 2018</xref>). The starting material was comprised of skin fibroblasts of parents of HGPS patients (Mother AG03257, Father HGADFN168), a healthy age matched child (GM08398) and two HGPS patient fibroblast samples (HGADFN167 and AG11513). Further, HGADFN168 and HGADFN167, belonging to a parent-child matched cells were analyzed both at an early and late passage: p12-27 and p12-19, respectively.</p><p>Briefly, ~5 million cells were fixed with 1% formaldehyde, suspended in cell lysis buffer for permeabilization, and homogenized by douncing. Crosslinked chromatin was digested overnight with HindIII (HGADFN167 and HGADFN168) or DpnII (HGADFN167, HGADFN168, AG03257 and AG11513). GM08398 cells were processed using the Arima-HiC +Kit from Arima Genomics following the protocol for Mammalian Cell Lines (A160134 v01). Sticky ends were filled in with biotin-dATP (Invitrogen), and the blunt ends of interacting fragments were ligated together. DNA was purified by two phenol-chloroform extractions and ethanol precipitation. Biotin-dATP at unligated ends was removed, and the DNA was sheared to a target size of 200–400 bp by a Covaris sonicator (Covaris, M220). DNA between 100–400 bp was selected for using AMPure XP beads (Beckman Coulter). Biotinylated DNA was pulled down using streptavidin coated magnetic beads and prepared for multiplex sequencing on an Illumina platform using the NEBNext Ultra II kit (NEB, E7645S). All end preparation, adaptor ligation, and PCR amplification steps were carried out on bead bound DNA libraries. Sequencing was carried out on Illumina HiSeq 3000 or NovaSeq platforms with 75 bp or 150 bp paired end reads. All Hi-C data statistics are presented in <xref ref-type="table" rid="app1table4">Appendix 1—table 4</xref>.</p></sec><sec id="s4-10"><title>Analysis of Hi-C data</title><p>Sequencing reads were mapped to the reference human genome hg19, filtered, and iteratively corrected using previously published pipelines (<xref ref-type="bibr" rid="bib38">Imakaev et al., 2012</xref>), available on github (<ext-link ext-link-type="uri" xlink:href="https://github.com/dekkerlab/cMapping">https://github.com/dekkerlab/cMapping</ext-link>). Publicly available tools (<ext-link ext-link-type="uri" xlink:href="https://github.com/dekkerlab/cworld-dekker">https://github.com/dekkerlab/cworld-dekker</ext-link>) were used to produce Hi-C heatmaps at 2.5 Mb and 250 kb resolution and to perform principal component analysis (using the matrix2compartment script) to generate compartment tracks at 250 kb resolution, assigning A and B compartments to positive and negative PC1 values, respectively. Values from replicate experiments were averaged, by bin, to produce the final compartment track. TAD boundary strength analysis was carried out using the insulation score approach (<xref ref-type="bibr" rid="bib11">Crane et al., 2015</xref>) (matrix2insulation) from this cworld package with 500 kb insulation square using 40 kb resolution contact maps.</p></sec><sec id="s4-11"><title>ChIP-seq data and processing: Lamin associated domain analysis</title><p>Raw LMNA ChIP-seq data was obtained from the <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/geo/">NCBI Gene Expression Omnibus</ext-link> (GEO) under accession number GSE41764 (<xref ref-type="bibr" rid="bib59">McCord et al., 2013</xref>). For comparison, DamID-seq for the fibroblast line HFFc6 (van Steensel Lab, Netherlands Cancer Institute) was obtained from the 4D Nucleome data portal (<xref ref-type="bibr" rid="bib16">Dekker et al., 2017</xref>; <xref ref-type="bibr" rid="bib68">Reiff et al., 2021</xref>), through the bio sample identifier <ext-link ext-link-type="uri" xlink:href="https://data.4dnucleome.org/biosamples/4DNBSR7TC87A/">4DNBSR7TC87A</ext-link>.</p><p>The fastq reads were first processed for adapter and quality trimming with the help of <ext-link ext-link-type="uri" xlink:href="https://github.com/kbaseapps/BBTools">BBDuk</ext-link> tool. The reads were then aligned to the hg19 reference genome using <ext-link ext-link-type="uri" xlink:href="https://github.com/alexdobin/STAR">STAR aligner</ext-link>. Finally, both the target and input mapped reads were binned at 40 kb resolution and log2-ratio of the target over the input bins was calculated using the ‘bamCompare’ function of <ext-link ext-link-type="uri" xlink:href="https://deeptools.readthedocs.io/">deepTools</ext-link> with parameters “<monospace>--operation</monospace> log2 -bs 40000 <monospace>--ignoreDuplicates</monospace> <monospace>--minMappingQuality</monospace> 30 <monospace>--scaleFactorsMethod</monospace> SES <monospace>--effectiveGenomeSize</monospace> 2864785220”.</p></sec></sec></body><back><sec sec-type="additional-information" id="s5"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interests</title><fn fn-type="COI-statement" id="conf1"><p>No competing interests declared</p></fn><fn fn-type="COI-statement" id="conf2"><p>No competing interests declared</p></fn></fn-group><fn-group content-type="author-contribution"><title>Author contributions</title><fn fn-type="con" id="con1"><p>Conceptualization, Formal analysis, Visualization, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con2"><p>Writing – review and editing, Investigation, Conceptualization, Writing – original draft</p></fn><fn fn-type="con" id="con3"><p>Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review and editing</p></fn><fn fn-type="con" id="con4"><p>Investigation, Data curation</p></fn><fn fn-type="con" id="con5"><p>Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Project administration, Supervision, Visualization, Writing – original draft, Writing – review and editing</p></fn></fn-group></sec><sec sec-type="supplementary-material" id="s6"><title>Additional files</title><supplementary-material id="mdar"><label>MDAR checklist</label><media xlink:href="elife-81290-mdarchecklist1-v2.pdf" mimetype="application" mime-subtype="pdf"/></supplementary-material></sec><sec sec-type="data-availability" id="s7"><title>Data availability</title><p>All RNA-seq and Hi-C data contributed by this study is available on GEO at GSE206707 (<ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206707">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206707</ext-link>).</p><p>The following dataset was generated:</p><p><element-citation publication-type="data" specific-use="isSupplementedBy" id="dataset1"><person-group person-group-type="author"><name><surname>San Martin</surname><given-names>R</given-names></name><name><surname>Das</surname><given-names>P</given-names></name><name><surname>Sanders</surname><given-names>JT</given-names></name><name><surname>Hill</surname><given-names>AM</given-names></name><name><surname>McCord</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE206707">GSE206707</pub-id></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation publication-type="data" specific-use="references" id="dataset2"><person-group person-group-type="author"><name><surname>Lyko</surname><given-names>F</given-names></name><name><surname>Rodriguez-Paredes</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>Epigenetic deregulation of lamina-associated domains in Hutchinson-Gilford Progeria Syndrome (RNA-Seq)</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE150137">GSE150137</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset3"><person-group person-group-type="author"><name><surname>Fleischer</surname><given-names>JG</given-names></name><name><surname>Schulte</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>H</given-names></name><name><surname>Tyagi</surname><given-names>S</given-names></name><name><surname>Ibarra</surname><given-names>A</given-names></name><name><surname>Shokhirev</surname><given-names>MN</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Hetzer</surname><given-names>MW</given-names></name><name><surname>Navlakha</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Predicting age from the transcriptome of human dermal fibroblasts</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113957">GSE113957</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset4"><person-group person-group-type="author"><name><surname>Ikegami</surname><given-names>K</given-names></name><name><surname>Secchia</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2020">2020</year><data-title>RNA-seq reported in &quot;Phosphorylated Lamin A/C in the nuclear interior binds active enhancers associated with abnormal transcription in progeria&quot;</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113343">GSE113343</pub-id></element-citation></p><p><element-citation publication-type="data" specific-use="references" id="dataset5"><person-group person-group-type="author"><name><surname>Mateos</surname><given-names>J</given-names></name><name><surname>Fafián-Labora</surname><given-names>J</given-names></name><name><surname>Morente-López</surname><given-names>M</given-names></name><name><surname>Lesende-Rodriguez</surname><given-names>I</given-names></name><name><surname>Monserrat</surname><given-names>L</given-names></name><name><surname>Ódena</surname><given-names>MA</given-names></name><name><surname>Oliveira</surname><given-names>E</given-names></name><name><surname>de Toro</surname><given-names>J</given-names></name><name><surname>Arufe</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2018">2018</year><data-title>Quantitative whole transcriptomics sequencing of progeria-derived cells point to a key role of nucleotide metabolism in premature aging</data-title><source>NCBI Gene Expression Omnibus</source><pub-id pub-id-type="accession" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE113648">GSE113648</pub-id></element-citation></p></sec><ack id="ack"><title>Acknowledgements</title><p>The authors thank Alvaro Rodriguez Gonzalez for his assistance with Hi-C data processing and Enrique Pacheco San Martin for his assistance with graphics and media design. The concept of the biology of priority during development and repair was adapted from discussion with, and coursework designed by, David Rowley Ph.D. (Baylor College of Medicine). This work was supported by NIH NIGMS Grant R35GM133557 to RPM. R San Martin was supported by a postdoctoral fellowship from the American Cancer Society (134060-PF-19-183-01-CSM).</p></ack><ref-list><title>References</title><ref id="bib1"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aguado</surname><given-names>J</given-names></name><name><surname>Sola-Carvajal</surname><given-names>A</given-names></name><name><surname>Cancila</surname><given-names>V</given-names></name><name><surname>Revêchon</surname><given-names>G</given-names></name><name><surname>Ong</surname><given-names>PF</given-names></name><name><surname>Jones-Weinert</surname><given-names>CW</given-names></name><name><surname>Wallén Arzt</surname><given-names>E</given-names></name><name><surname>Lattanzi</surname><given-names>G</given-names></name><name><surname>Dreesen</surname><given-names>O</given-names></name><name><surname>Tripodo</surname><given-names>C</given-names></name><name><surname>Rossiello</surname><given-names>F</given-names></name><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>d’Adda di Fagagna</surname><given-names>F</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of hutchinson-gilford progeria syndrome</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>4990</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-13018-3</pub-id><pub-id pub-id-type="pmid">31740672</pub-id></element-citation></ref><ref id="bib2"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrade</surname><given-names>AC</given-names></name><name><surname>Jee</surname><given-names>YH</given-names></name><name><surname>Nilsson</surname><given-names>O</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>New genetic diagnoses of short stature provide insights into local regulation of childhood growth</article-title><source>Hormone Research in Paediatrics</source><volume>88</volume><fpage>22</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1159/000455850</pub-id><pub-id pub-id-type="pmid">28334714</pub-id></element-citation></ref><ref id="bib3"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andrzejewska</surname><given-names>A</given-names></name><name><surname>Lukomska</surname><given-names>B</given-names></name><name><surname>Janowski</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Concise review: mesenchymal stem cells: from roots to boost</article-title><source>Stem Cells</source><volume>37</volume><fpage>855</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1002/stem.3016</pub-id><pub-id pub-id-type="pmid">30977255</pub-id></element-citation></ref><ref id="bib4"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Apte</surname><given-names>K</given-names></name><name><surname>Stick</surname><given-names>R</given-names></name><name><surname>Radmacher</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mechanics in human fibroblasts and progeria: lamin a mutation E145K results in stiffening of nuclei</article-title><source>Journal of Molecular Recognition</source><volume>30</volume><elocation-id>2580</elocation-id><pub-id pub-id-type="doi">10.1002/jmr.2580</pub-id><pub-id pub-id-type="pmid">27677907</pub-id></element-citation></ref><ref id="bib5"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bellotti</surname><given-names>C</given-names></name><name><surname>Capanni</surname><given-names>C</given-names></name><name><surname>Lattanzi</surname><given-names>G</given-names></name><name><surname>Donati</surname><given-names>D</given-names></name><name><surname>Lucarelli</surname><given-names>E</given-names></name><name><surname>Duchi</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Detection of mesenchymal stem cells senescence by prelamin a accumulation at the nuclear level</article-title><source>SpringerPlus</source><volume>5</volume><elocation-id>1427</elocation-id><pub-id pub-id-type="doi">10.1186/s40064-016-3091-7</pub-id><pub-id pub-id-type="pmid">27625981</pub-id></element-citation></ref><ref id="bib6"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bradley</surname><given-names>EW</given-names></name><name><surname>Drissi</surname><given-names>MH</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Wnt5A regulates chondrocyte differentiation through differential use of the can/NFAT and IKK/NF-kappab pathways</article-title><source>Molecular Endocrinology</source><volume>24</volume><fpage>1581</fpage><lpage>1593</lpage><pub-id pub-id-type="doi">10.1210/me.2010-0037</pub-id><pub-id pub-id-type="pmid">20573686</pub-id></element-citation></ref><ref id="bib7"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bridger</surname><given-names>JM</given-names></name><name><surname>Kill</surname><given-names>IR</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Aging of Hutchinson-Gilford progeria syndrome fibroblasts is characterised by hyperproliferation and increased apoptosis</article-title><source>Experimental Gerontology</source><volume>39</volume><fpage>717</fpage><lpage>724</lpage><pub-id pub-id-type="doi">10.1016/j.exger.2004.02.002</pub-id><pub-id pub-id-type="pmid">15130666</pub-id></element-citation></ref><ref id="bib8"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Butala</surname><given-names>P</given-names></name><name><surname>Szpalski</surname><given-names>C</given-names></name><name><surname>Soares</surname><given-names>M</given-names></name><name><surname>Davidson</surname><given-names>EH</given-names></name><name><surname>Knobel</surname><given-names>D</given-names></name><name><surname>Warren</surname><given-names>SM</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Zmpste24-/- mouse model for senescent wound healing research</article-title><source>Plastic and Reconstructive Surgery</source><volume>130</volume><fpage>788e</fpage><lpage>798e</lpage><pub-id pub-id-type="doi">10.1097/PRS.0b013e31826d102b</pub-id><pub-id pub-id-type="pmid">23190830</pub-id></element-citation></ref><ref id="bib9"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chawla</surname><given-names>GS</given-names></name><name><surname>Agrawal</surname><given-names>PM</given-names></name><name><surname>Dhok</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Progeria: an extremely unusual disorder</article-title><source>Skeletal Radiology</source><volume>46</volume><fpage>1149</fpage><lpage>1153</lpage><pub-id pub-id-type="doi">10.1007/s00256-017-2673-y</pub-id><pub-id pub-id-type="pmid">28540519</pub-id></element-citation></ref><ref id="bib10"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cleveland</surname><given-names>RH</given-names></name><name><surname>Gordon</surname><given-names>LB</given-names></name><name><surname>Kleinman</surname><given-names>ME</given-names></name><name><surname>Miller</surname><given-names>DT</given-names></name><name><surname>Gordon</surname><given-names>CM</given-names></name><name><surname>Snyder</surname><given-names>BD</given-names></name><name><surname>Nazarian</surname><given-names>A</given-names></name><name><surname>Giobbie-Hurder</surname><given-names>A</given-names></name><name><surname>Neuberg</surname><given-names>D</given-names></name><name><surname>Kieran</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>A prospective study of radiographic manifestations in Hutchinson-Gilford progeria syndrome</article-title><source>Pediatric Radiology</source><volume>42</volume><fpage>1089</fpage><lpage>1098</lpage><pub-id pub-id-type="doi">10.1007/s00247-012-2423-1</pub-id><pub-id pub-id-type="pmid">22752073</pub-id></element-citation></ref><ref id="bib11"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crane</surname><given-names>E</given-names></name><name><surname>Bian</surname><given-names>Q</given-names></name><name><surname>McCord</surname><given-names>RP</given-names></name><name><surname>Lajoie</surname><given-names>BR</given-names></name><name><surname>Wheeler</surname><given-names>BS</given-names></name><name><surname>Ralston</surname><given-names>EJ</given-names></name><name><surname>Uzawa</surname><given-names>S</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Meyer</surname><given-names>BJ</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Condensin-driven remodelling of X chromosome topology during dosage compensation</article-title><source>Nature</source><volume>523</volume><fpage>240</fpage><lpage>244</lpage><pub-id pub-id-type="doi">10.1038/nature14450</pub-id><pub-id pub-id-type="pmid">26030525</pub-id></element-citation></ref><ref id="bib12"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crasto</surname><given-names>S</given-names></name><name><surname>Di Pasquale</surname><given-names>E</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Induced pluripotent stem cells to study mechanisms of laminopathies: focus on epigenetics</article-title><source>Frontiers in Cell and Developmental Biology</source><volume>6</volume><elocation-id>172</elocation-id><pub-id pub-id-type="doi">10.3389/fcell.2018.00172</pub-id><pub-id pub-id-type="pmid">30619852</pub-id></element-citation></ref><ref id="bib13"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crisan</surname><given-names>M</given-names></name><name><surname>Yap</surname><given-names>S</given-names></name><name><surname>Casteilla</surname><given-names>L</given-names></name><name><surname>Chen</surname><given-names>C-W</given-names></name><name><surname>Corselli</surname><given-names>M</given-names></name><name><surname>Park</surname><given-names>TS</given-names></name><name><surname>Andriolo</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>B</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Norotte</surname><given-names>C</given-names></name><name><surname>Teng</surname><given-names>P-N</given-names></name><name><surname>Traas</surname><given-names>J</given-names></name><name><surname>Schugar</surname><given-names>R</given-names></name><name><surname>Deasy</surname><given-names>BM</given-names></name><name><surname>Badylak</surname><given-names>S</given-names></name><name><surname>Buhring</surname><given-names>H-J</given-names></name><name><surname>Giacobino</surname><given-names>J-P</given-names></name><name><surname>Lazzari</surname><given-names>L</given-names></name><name><surname>Huard</surname><given-names>J</given-names></name><name><surname>Péault</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A perivascular origin for mesenchymal stem cells in multiple human organs</article-title><source>Cell Stem Cell</source><volume>3</volume><fpage>301</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2008.07.003</pub-id><pub-id pub-id-type="pmid">18786417</pub-id></element-citation></ref><ref id="bib14"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Csoka</surname><given-names>AB</given-names></name><name><surname>English</surname><given-names>SB</given-names></name><name><surname>Simkevich</surname><given-names>CP</given-names></name><name><surname>Ginzinger</surname><given-names>DG</given-names></name><name><surname>Butte</surname><given-names>AJ</given-names></name><name><surname>Schatten</surname><given-names>GP</given-names></name><name><surname>Rothman</surname><given-names>FG</given-names></name><name><surname>Sedivy</surname><given-names>JM</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Genome-Scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis</article-title><source>Aging Cell</source><volume>3</volume><fpage>235</fpage><lpage>243</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9728.2004.00105.x</pub-id><pub-id pub-id-type="pmid">15268757</pub-id></element-citation></ref><ref id="bib15"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davies</surname><given-names>BSJ</given-names></name><name><surname>Fong</surname><given-names>LG</given-names></name><name><surname>Yang</surname><given-names>SH</given-names></name><name><surname>Coffinier</surname><given-names>C</given-names></name><name><surname>Young</surname><given-names>SG</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>The posttranslational processing of prelamin A and disease</article-title><source>Annual Review of Genomics and Human Genetics</source><volume>10</volume><fpage>153</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.1146/annurev-genom-082908-150150</pub-id><pub-id pub-id-type="pmid">19453251</pub-id></element-citation></ref><ref id="bib16"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Belmont</surname><given-names>AS</given-names></name><name><surname>Guttman</surname><given-names>M</given-names></name><name><surname>Leshyk</surname><given-names>VO</given-names></name><name><surname>Lis</surname><given-names>JT</given-names></name><name><surname>Lomvardas</surname><given-names>S</given-names></name><name><surname>Mirny</surname><given-names>LA</given-names></name><name><surname>O’Shea</surname><given-names>CC</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name><name><surname>Ren</surname><given-names>B</given-names></name><name><surname>Politz</surname><given-names>JCR</given-names></name><name><surname>Shendure</surname><given-names>J</given-names></name><name><surname>Zhong</surname><given-names>S</given-names></name><collab>4D Nucleome Network</collab></person-group><year iso-8601-date="2017">2017</year><article-title>The 4D nucleome project</article-title><source>Nature</source><volume>549</volume><fpage>219</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1038/nature23884</pub-id><pub-id pub-id-type="pmid">28905911</pub-id></element-citation></ref><ref id="bib17"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denu</surname><given-names>RA</given-names></name><name><surname>Nemcek</surname><given-names>S</given-names></name><name><surname>Bloom</surname><given-names>DD</given-names></name><name><surname>Goodrich</surname><given-names>AD</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Mosher</surname><given-names>DF</given-names></name><name><surname>Hematti</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Fibroblasts and mesenchymal stromal/stem cells are phenotypically indistinguishable</article-title><source>Acta Haematologica</source><volume>136</volume><fpage>85</fpage><lpage>97</lpage><pub-id pub-id-type="doi">10.1159/000445096</pub-id><pub-id pub-id-type="pmid">27188909</pub-id></element-citation></ref><ref id="bib18"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Sandre-Giovannoli</surname><given-names>A</given-names></name><name><surname>Bernard</surname><given-names>R</given-names></name><name><surname>Cau</surname><given-names>P</given-names></name><name><surname>Navarro</surname><given-names>C</given-names></name><name><surname>Amiel</surname><given-names>J</given-names></name><name><surname>Boccaccio</surname><given-names>I</given-names></name><name><surname>Lyonnet</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>CL</given-names></name><name><surname>Munnich</surname><given-names>A</given-names></name><name><surname>Le Merrer</surname><given-names>M</given-names></name><name><surname>Lévy</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Lamin a truncation in hutchinson-gilford progeria</article-title><source>Science</source><volume>300</volume><elocation-id>2055</elocation-id><pub-id pub-id-type="doi">10.1126/science.1084125</pub-id><pub-id pub-id-type="pmid">12702809</pub-id></element-citation></ref><ref id="bib19"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Carlo</surname><given-names>SE</given-names></name><name><surname>Peduto</surname><given-names>L</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>The perivascular origin of pathological fibroblasts</article-title><source>The Journal of Clinical Investigation</source><volume>128</volume><fpage>54</fpage><lpage>63</lpage><pub-id pub-id-type="doi">10.1172/JCI93558</pub-id><pub-id pub-id-type="pmid">29293094</pub-id></element-citation></ref><ref id="bib20"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diméglio</surname><given-names>A</given-names></name><name><surname>Charles</surname><given-names>YP</given-names></name><name><surname>Daures</surname><given-names>J-P</given-names></name><name><surname>de Rosa</surname><given-names>V</given-names></name><name><surname>Kaboré</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Accuracy of the sauvegrain method in determining skeletal age during puberty</article-title><source>The Journal of Bone and Joint Surgery. American Volume</source><volume>87</volume><fpage>1689</fpage><lpage>1696</lpage><pub-id pub-id-type="doi">10.2106/JBJS.D.02418</pub-id><pub-id pub-id-type="pmid">16085606</pub-id></element-citation></ref><ref id="bib21"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Direkze</surname><given-names>NC</given-names></name><name><surname>Hodivala-Dilke</surname><given-names>K</given-names></name><name><surname>Jeffery</surname><given-names>R</given-names></name><name><surname>Hunt</surname><given-names>T</given-names></name><name><surname>Poulsom</surname><given-names>R</given-names></name><name><surname>Oukrif</surname><given-names>D</given-names></name><name><surname>Alison</surname><given-names>MR</given-names></name><name><surname>Wright</surname><given-names>NA</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts</article-title><source>Cancer Research</source><volume>64</volume><fpage>8492</fpage><lpage>8495</lpage><pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-1708</pub-id><pub-id pub-id-type="pmid">15574751</pub-id></element-citation></ref><ref id="bib22"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>El Agha</surname><given-names>E</given-names></name><name><surname>Kramann</surname><given-names>R</given-names></name><name><surname>Schneider</surname><given-names>RK</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Seeger</surname><given-names>W</given-names></name><name><surname>Humphreys</surname><given-names>BD</given-names></name><name><surname>Bellusci</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Mesenchymal stem cells in fibrotic disease</article-title><source>Cell Stem Cell</source><volume>21</volume><fpage>166</fpage><lpage>177</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2017.07.011</pub-id><pub-id pub-id-type="pmid">28777943</pub-id></element-citation></ref><ref id="bib23"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>Brown</surname><given-names>WT</given-names></name><name><surname>Gordon</surname><given-names>LB</given-names></name><name><surname>Glynn</surname><given-names>MW</given-names></name><name><surname>Singer</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>L</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Robbins</surname><given-names>CM</given-names></name><name><surname>Moses</surname><given-names>TY</given-names></name><name><surname>Berglund</surname><given-names>P</given-names></name><name><surname>Dutra</surname><given-names>A</given-names></name><name><surname>Pak</surname><given-names>E</given-names></name><name><surname>Durkin</surname><given-names>S</given-names></name><name><surname>Csoka</surname><given-names>AB</given-names></name><name><surname>Boehnke</surname><given-names>M</given-names></name><name><surname>Glover</surname><given-names>TW</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Recurrent de novo point mutations in lamin a cause Hutchinson-Gilford progeria syndrome</article-title><source>Nature</source><volume>423</volume><fpage>293</fpage><lpage>298</lpage><pub-id pub-id-type="doi">10.1038/nature01629</pub-id><pub-id pub-id-type="pmid">12714972</pub-id></element-citation></ref><ref id="bib24"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferguson</surname><given-names>D</given-names></name><name><surname>Scott</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The enigmatic role and development of the clavicle</article-title><source>ORTHOPAEDICS AND TRAUMA</source><volume>30</volume><fpage>273</fpage><lpage>276</lpage><pub-id pub-id-type="doi">10.1016/j.mporth.2015.05.002</pub-id></element-citation></ref><ref id="bib25"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fleischer</surname><given-names>JG</given-names></name><name><surname>Schulte</surname><given-names>R</given-names></name><name><surname>Tsai</surname><given-names>HH</given-names></name><name><surname>Tyagi</surname><given-names>S</given-names></name><name><surname>Ibarra</surname><given-names>A</given-names></name><name><surname>Shokhirev</surname><given-names>MN</given-names></name><name><surname>Huang</surname><given-names>L</given-names></name><name><surname>Hetzer</surname><given-names>MW</given-names></name><name><surname>Navlakha</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Predicting age from the transcriptome of human dermal fibroblasts</article-title><source>Genome Biology</source><volume>19</volume><elocation-id>221</elocation-id><pub-id pub-id-type="doi">10.1186/s13059-018-1599-6</pub-id><pub-id pub-id-type="pmid">30567591</pub-id></element-citation></ref><ref id="bib26"><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Foundation</surname><given-names>PR</given-names></name></person-group><year iso-8601-date="2019">2019</year><source>The Progeria Handbook. A Guide for Families &amp; Health Care Providers of Children with Progeria</source><publisher-name>Progeria Research Foundation</publisher-name></element-citation></ref><ref id="bib27"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gilford</surname><given-names>H</given-names></name><name><surname>Hutchinson</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1897">1897</year><article-title>On a condition of mixed premature and immature development</article-title><source>Journal of the Royal Society of Medicine</source><volume>MCT-80</volume><fpage>17</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1177/095952879708000105</pub-id></element-citation></ref><ref id="bib28"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldman</surname><given-names>RD</given-names></name><name><surname>Shumaker</surname><given-names>DK</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Eriksson</surname><given-names>M</given-names></name><name><surname>Goldman</surname><given-names>AE</given-names></name><name><surname>Gordon</surname><given-names>LB</given-names></name><name><surname>Gruenbaum</surname><given-names>Y</given-names></name><name><surname>Khuon</surname><given-names>S</given-names></name><name><surname>Mendez</surname><given-names>M</given-names></name><name><surname>Varga</surname><given-names>R</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Accumulation of mutant lamin a causes progressive changes in nuclear architecture in hutchinson-gilford progeria syndrome</article-title><source>PNAS</source><volume>101</volume><fpage>8963</fpage><lpage>8968</lpage><pub-id pub-id-type="doi">10.1073/pnas.0402943101</pub-id><pub-id pub-id-type="pmid">15184648</pub-id></element-citation></ref><ref id="bib29"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Golloshi</surname><given-names>R</given-names></name><name><surname>Sanders</surname><given-names>JT</given-names></name><name><surname>McCord</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Iteratively improving hi-C experiments one step at a time</article-title><source>Methods</source><volume>142</volume><fpage>47</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2018.04.033</pub-id><pub-id pub-id-type="pmid">29723572</pub-id></element-citation></ref><ref id="bib30"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalo</surname><given-names>S</given-names></name><name><surname>Kreienkamp</surname><given-names>R</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Dna repair defects and genome instability in hutchinson–gilford progeria syndrome</article-title><source>Current Opinion in Cell Biology</source><volume>34</volume><fpage>75</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/j.ceb.2015.05.007</pub-id><pub-id pub-id-type="pmid">26079711</pub-id></element-citation></ref><ref id="bib31"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonzalo</surname><given-names>S</given-names></name><name><surname>Coll-Bonfill</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Genomic instability and innate immune responses to self-DNA in progeria</article-title><source>GeroScience</source><volume>41</volume><fpage>255</fpage><lpage>266</lpage><pub-id pub-id-type="doi">10.1007/s11357-019-00082-2</pub-id><pub-id pub-id-type="pmid">31280482</pub-id></element-citation></ref><ref id="bib32"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gordon</surname><given-names>CM</given-names></name><name><surname>Gordon</surname><given-names>LB</given-names></name><name><surname>Snyder</surname><given-names>BD</given-names></name><name><surname>Nazarian</surname><given-names>A</given-names></name><name><surname>Quinn</surname><given-names>N</given-names></name><name><surname>Huh</surname><given-names>S</given-names></name><name><surname>Giobbie-Hurder</surname><given-names>A</given-names></name><name><surname>Neuberg</surname><given-names>D</given-names></name><name><surname>Cleveland</surname><given-names>R</given-names></name><name><surname>Kleinman</surname><given-names>M</given-names></name><name><surname>Miller</surname><given-names>DT</given-names></name><name><surname>Kieran</surname><given-names>MW</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Hutchinson-gilford progeria is a skeletal dysplasia</article-title><source>Journal of Bone and Mineral Research</source><volume>26</volume><fpage>1670</fpage><lpage>1679</lpage><pub-id pub-id-type="doi">10.1002/jbmr.392</pub-id><pub-id pub-id-type="pmid">21445982</pub-id></element-citation></ref><ref id="bib33"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Green</surname><given-names>JD</given-names></name><name><surname>Tollemar</surname><given-names>V</given-names></name><name><surname>Dougherty</surname><given-names>M</given-names></name><name><surname>Yan</surname><given-names>Z</given-names></name><name><surname>Yin</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Collier</surname><given-names>Z</given-names></name><name><surname>Mohammed</surname><given-names>MK</given-names></name><name><surname>Haydon</surname><given-names>RC</given-names></name><name><surname>Luu</surname><given-names>HH</given-names></name><name><surname>Kang</surname><given-names>R</given-names></name><name><surname>Lee</surname><given-names>MJ</given-names></name><name><surname>Ho</surname><given-names>SH</given-names></name><name><surname>He</surname><given-names>T-C</given-names></name><name><surname>Shi</surname><given-names>LL</given-names></name><name><surname>Athiviraham</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Multifaceted signaling regulators of chondrogenesis: implications in cartilage regeneration and tissue engineering</article-title><source>Genes &amp; Diseases</source><volume>2</volume><fpage>307</fpage><lpage>327</lpage><pub-id pub-id-type="doi">10.1016/j.gendis.2015.09.003</pub-id><pub-id pub-id-type="pmid">26835506</pub-id></element-citation></ref><ref id="bib34"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamczyk</surname><given-names>MR</given-names></name><name><surname>Villa-Bellosta</surname><given-names>R</given-names></name><name><surname>Gonzalo</surname><given-names>P</given-names></name><name><surname>Andrés-Manzano</surname><given-names>MJ</given-names></name><name><surname>Nogales</surname><given-names>P</given-names></name><name><surname>Bentzon</surname><given-names>JF</given-names></name><name><surname>López-Otín</surname><given-names>C</given-names></name><name><surname>Andrés</surname><given-names>V</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Vascular smooth muscle–specific progerin expression accelerates atherosclerosis and death in a mouse model of Hutchinson-Gilford progeria syndrome</article-title><source>Circulation</source><volume>138</volume><fpage>266</fpage><lpage>282</lpage><pub-id pub-id-type="doi">10.1161/CIRCULATIONAHA.117.030856</pub-id><pub-id pub-id-type="pmid">29490993</pub-id></element-citation></ref><ref id="bib35"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>L</given-names></name><name><surname>Roux</surname><given-names>KJ</given-names></name><name><surname>Wong</surname><given-names>ESM</given-names></name><name><surname>Mounkes</surname><given-names>LC</given-names></name><name><surname>Mutalif</surname><given-names>R</given-names></name><name><surname>Navasankari</surname><given-names>R</given-names></name><name><surname>Rai</surname><given-names>B</given-names></name><name><surname>Cool</surname><given-names>S</given-names></name><name><surname>Jeong</surname><given-names>J-W</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Lee</surname><given-names>H-S</given-names></name><name><surname>Kozlov</surname><given-names>S</given-names></name><name><surname>Grunert</surname><given-names>M</given-names></name><name><surname>Keeble</surname><given-names>T</given-names></name><name><surname>Jones</surname><given-names>CM</given-names></name><name><surname>Meta</surname><given-names>MD</given-names></name><name><surname>Young</surname><given-names>SG</given-names></name><name><surname>Daar</surname><given-names>IO</given-names></name><name><surname>Burke</surname><given-names>B</given-names></name><name><surname>Perantoni</surname><given-names>AO</given-names></name><name><surname>Stewart</surname><given-names>CL</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>Functional coupling between the extracellular matrix and nuclear lamina by wnt signaling in progeria</article-title><source>Developmental Cell</source><volume>19</volume><fpage>413</fpage><lpage>425</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2010.08.013</pub-id><pub-id pub-id-type="pmid">20833363</pub-id></element-citation></ref><ref id="bib36"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hutchinson</surname><given-names>J</given-names></name></person-group><year iso-8601-date="1886">1886</year><article-title>Congenital absence of hair and mammary glands with atrophic condition of the skin and its appendages, in a Boy whose mother had been almost wholly bald from alopecia areata from the age of six</article-title><source>Medico-Chirurgical Transactions</source><volume>69</volume><fpage>473</fpage><lpage>477</lpage><pub-id pub-id-type="doi">10.1177/095952878606900127</pub-id><pub-id pub-id-type="pmid">20896687</pub-id></element-citation></ref><ref id="bib37"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ikegami</surname><given-names>K</given-names></name><name><surname>Secchia</surname><given-names>S</given-names></name><name><surname>Almakki</surname><given-names>O</given-names></name><name><surname>Lieb</surname><given-names>JD</given-names></name><name><surname>Moskowitz</surname><given-names>IP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Phosphorylated lamin A/C in the nuclear interior binds active enhancers associated with abnormal transcription in progeria</article-title><source>Developmental Cell</source><volume>52</volume><fpage>699</fpage><lpage>713</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2020.02.011</pub-id><pub-id pub-id-type="pmid">32208162</pub-id></element-citation></ref><ref id="bib38"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Imakaev</surname><given-names>M</given-names></name><name><surname>Fudenberg</surname><given-names>G</given-names></name><name><surname>McCord</surname><given-names>RP</given-names></name><name><surname>Naumova</surname><given-names>N</given-names></name><name><surname>Goloborodko</surname><given-names>A</given-names></name><name><surname>Lajoie</surname><given-names>BR</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Mirny</surname><given-names>LA</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Iterative correction of hi-C data reveals hallmarks of chromosome organization</article-title><source>Nature Methods</source><volume>9</volume><fpage>999</fpage><lpage>1003</lpage><pub-id pub-id-type="doi">10.1038/nmeth.2148</pub-id><pub-id pub-id-type="pmid">22941365</pub-id></element-citation></ref><ref id="bib39"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Infante</surname><given-names>A</given-names></name><name><surname>Rodríguez</surname><given-names>CI</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>Cell and cell-free therapies to counteract human premature and physiological aging: MscS come to light</article-title><source>Journal of Personalized Medicine</source><volume>11</volume><elocation-id>1043</elocation-id><pub-id pub-id-type="doi">10.3390/jpm11101043</pub-id><pub-id pub-id-type="pmid">34683184</pub-id></element-citation></ref><ref id="bib40"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>W</given-names></name><name><surname>Barron</surname><given-names>DA</given-names></name><name><surname>San Martin</surname><given-names>R</given-names></name><name><surname>Chan</surname><given-names>KS</given-names></name><name><surname>Tran</surname><given-names>LL</given-names></name><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Ressler</surname><given-names>SJ</given-names></name><name><surname>Rowley</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>RUNX1 is essential for mesenchymal stem cell proliferation and myofibroblast differentiation</article-title><source>PNAS</source><volume>111</volume><fpage>16389</fpage><lpage>16394</lpage><pub-id pub-id-type="doi">10.1073/pnas.1407097111</pub-id><pub-id pub-id-type="pmid">25313057</pub-id></element-citation></ref><ref id="bib41"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koblan</surname><given-names>LW</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Wilson</surname><given-names>C</given-names></name><name><surname>Cabral</surname><given-names>WA</given-names></name><name><surname>Levy</surname><given-names>JM</given-names></name><name><surname>Xiong</surname><given-names>Z-M</given-names></name><name><surname>Tavarez</surname><given-names>UL</given-names></name><name><surname>Davison</surname><given-names>LM</given-names></name><name><surname>Gete</surname><given-names>YG</given-names></name><name><surname>Mao</surname><given-names>X</given-names></name><name><surname>Newby</surname><given-names>GA</given-names></name><name><surname>Doherty</surname><given-names>SP</given-names></name><name><surname>Narisu</surname><given-names>N</given-names></name><name><surname>Sheng</surname><given-names>Q</given-names></name><name><surname>Krilow</surname><given-names>C</given-names></name><name><surname>Lin</surname><given-names>CY</given-names></name><name><surname>Gordon</surname><given-names>LB</given-names></name><name><surname>Cao</surname><given-names>K</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Brown</surname><given-names>JD</given-names></name><name><surname>Liu</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>In vivo base editing rescues Hutchinson-Gilford progeria syndrome in mice</article-title><source>Nature</source><volume>589</volume><fpage>608</fpage><lpage>614</lpage><pub-id pub-id-type="doi">10.1038/s41586-020-03086-7</pub-id><pub-id pub-id-type="pmid">33408413</pub-id></element-citation></ref><ref id="bib42"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Köhler</surname><given-names>F</given-names></name><name><surname>Bormann</surname><given-names>F</given-names></name><name><surname>Raddatz</surname><given-names>G</given-names></name><name><surname>Gutekunst</surname><given-names>J</given-names></name><name><surname>Corless</surname><given-names>S</given-names></name><name><surname>Musch</surname><given-names>T</given-names></name><name><surname>Lonsdorf</surname><given-names>AS</given-names></name><name><surname>Erhardt</surname><given-names>S</given-names></name><name><surname>Lyko</surname><given-names>F</given-names></name><name><surname>Rodríguez-Paredes</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Epigenetic deregulation of lamina-associated domains in hutchinson-gilford progeria syndrome</article-title><source>Genome Medicine</source><volume>12</volume><elocation-id>46</elocation-id><pub-id pub-id-type="doi">10.1186/s13073-020-00749-y</pub-id><pub-id pub-id-type="pmid">32450911</pub-id></element-citation></ref><ref id="bib43"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Komari</surname><given-names>CJ</given-names></name><name><surname>Guttman</surname><given-names>AO</given-names></name><name><surname>Carr</surname><given-names>SR</given-names></name><name><surname>Trachtenberg</surname><given-names>TL</given-names></name><name><surname>Orloff</surname><given-names>EA</given-names></name><name><surname>Haas</surname><given-names>AV</given-names></name><name><surname>Patrick</surname><given-names>AR</given-names></name><name><surname>Chowdhary</surname><given-names>S</given-names></name><name><surname>Waldman</surname><given-names>BC</given-names></name><name><surname>Waldman</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Alteration of genetic recombination and double-strand break repair in human cells by progerin expression</article-title><source>DNA Repair</source><volume>96</volume><elocation-id>102975</elocation-id><pub-id pub-id-type="doi">10.1016/j.dnarep.2020.102975</pub-id><pub-id pub-id-type="pmid">33010688</pub-id></element-citation></ref><ref id="bib44"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lajoie</surname><given-names>BR</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Kaplan</surname><given-names>N</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>The hitchhiker’s guide to hi-C analysis: practical guidelines</article-title><source>Methods</source><volume>72</volume><fpage>65</fpage><lpage>75</lpage><pub-id pub-id-type="doi">10.1016/j.ymeth.2014.10.031</pub-id><pub-id pub-id-type="pmid">25448293</pub-id></element-citation></ref><ref id="bib45"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Lajoie</surname><given-names>B</given-names></name><name><surname>Oomen</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2015">2015</year><data-title>CMapping</data-title><version designator="v1.0.6">v1.0.6</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/dekkerlab/cMapping">https://github.com/dekkerlab/cMapping</ext-link></element-citation></ref><ref id="bib46"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Lajoie</surname><given-names>B</given-names></name><name><surname>Venev</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2019">2019</year><data-title>Cworld::dekker</data-title><version designator="v0.41.1">v0.41.1</version><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/dekkerlab/cworld-dekker">https://github.com/dekkerlab/cworld-dekker</ext-link></element-citation></ref><ref id="bib47"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lamagna</surname><given-names>C</given-names></name><name><surname>Bergers</surname><given-names>G</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>The bone marrow constitutes a reservoir of pericyte progenitors</article-title><source>Journal of Leukocyte Biology</source><volume>80</volume><fpage>677</fpage><lpage>681</lpage><pub-id pub-id-type="doi">10.1189/jlb.0506309</pub-id><pub-id pub-id-type="pmid">16888086</pub-id></element-citation></ref><ref id="bib48"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lammerding</surname><given-names>J</given-names></name><name><surname>Schulze</surname><given-names>PC</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name><name><surname>Kozlov</surname><given-names>S</given-names></name><name><surname>Sullivan</surname><given-names>T</given-names></name><name><surname>Kamm</surname><given-names>RD</given-names></name><name><surname>Stewart</surname><given-names>CL</given-names></name><name><surname>Lee</surname><given-names>RT</given-names></name></person-group><year iso-8601-date="2004">2004</year><article-title>Lamin A/C deficiency causes defective nuclear mechanics and mechanotransduction</article-title><source>The Journal of Clinical Investigation</source><volume>113</volume><fpage>370</fpage><lpage>378</lpage><pub-id pub-id-type="doi">10.1172/JCI19670</pub-id><pub-id pub-id-type="pmid">14755334</pub-id></element-citation></ref><ref id="bib49"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langley</surname><given-names>NR</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>The lateral clavicular epiphysis: fusion timing and age estimation</article-title><source>International Journal of Legal Medicine</source><volume>130</volume><fpage>511</fpage><lpage>517</lpage><pub-id pub-id-type="doi">10.1007/s00414-015-1236-9</pub-id><pub-id pub-id-type="pmid">26253853</pub-id></element-citation></ref><ref id="bib50"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>LeBleu</surname><given-names>VS</given-names></name><name><surname>Neilson</surname><given-names>EG</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Origin and functional heterogeneity of fibroblasts</article-title><source>FASEB Journal</source><volume>34</volume><fpage>3519</fpage><lpage>3536</lpage><pub-id pub-id-type="doi">10.1096/fj.201903188R</pub-id><pub-id pub-id-type="pmid">32037627</pub-id></element-citation></ref><ref id="bib51"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leemans</surname><given-names>C</given-names></name><name><surname>van der Zwalm</surname><given-names>MCH</given-names></name><name><surname>Brueckner</surname><given-names>L</given-names></name><name><surname>Comoglio</surname><given-names>F</given-names></name><name><surname>van Schaik</surname><given-names>T</given-names></name><name><surname>Pagie</surname><given-names>L</given-names></name><name><surname>van Arensbergen</surname><given-names>J</given-names></name><name><surname>van Steensel</surname><given-names>B</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Promoter-intrinsic and local chromatin features determine gene repression in lads</article-title><source>Cell</source><volume>177</volume><fpage>852</fpage><lpage>864</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2019.03.009</pub-id><pub-id pub-id-type="pmid">30982597</pub-id></element-citation></ref><ref id="bib52"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lemire</surname><given-names>JM</given-names></name><name><surname>Patis</surname><given-names>C</given-names></name><name><surname>Gordon</surname><given-names>LB</given-names></name><name><surname>Sandy</surname><given-names>JD</given-names></name><name><surname>Toole</surname><given-names>BP</given-names></name><name><surname>Weiss</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2006">2006</year><article-title>Aggrecan expression is substantially and abnormally upregulated in Hutchinson-Gilford progeria syndrome dermal fibroblasts</article-title><source>Mechanisms of Ageing and Development</source><volume>127</volume><fpage>660</fpage><lpage>669</lpage><pub-id pub-id-type="doi">10.1016/j.mad.2006.03.004</pub-id><pub-id pub-id-type="pmid">16650460</pub-id></element-citation></ref><ref id="bib53"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name></person-group><year iso-8601-date="2022">2022</year><data-title>Bwa</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/lh3/bwa">https://github.com/lh3/bwa</ext-link></element-citation></ref><ref id="bib54"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Z</given-names></name><name><surname>Ji</surname><given-names>Q</given-names></name><name><surname>Ren</surname><given-names>J</given-names></name><name><surname>Yan</surname><given-names>P</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>G</given-names></name><name><surname>Liang</surname><given-names>C</given-names></name><name><surname>Sun</surname><given-names>R</given-names></name><name><surname>Jiang</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Bi</surname><given-names>S</given-names></name><name><surname>Wei</surname><given-names>G</given-names></name><name><surname>Cao</surname><given-names>G</given-names></name><name><surname>Zhao</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Zhou</surname><given-names>Q</given-names></name><name><surname>Belmonte</surname><given-names>JCI</given-names></name><name><surname>Qu</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>G-H</given-names></name></person-group><year iso-8601-date="2022">2022</year><article-title>Large-Scale chromatin reorganization reactivates placenta-specific genes that drive cellular aging</article-title><source>Developmental Cell</source><volume>57</volume><fpage>1347</fpage><lpage>1368</lpage><pub-id pub-id-type="doi">10.1016/j.devcel.2022.05.004</pub-id><pub-id pub-id-type="pmid">35613614</pub-id></element-citation></ref><ref id="bib55"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Cicero</surname><given-names>A</given-names></name><name><surname>Nissan</surname><given-names>X</given-names></name></person-group><year iso-8601-date="2015">2015</year><article-title>Pluripotent stem cells to model Hutchinson-Gilford progeria syndrome (HGPS): current trends and future perspectives for drug discovery</article-title><source>Ageing Research Reviews</source><volume>24</volume><fpage>343</fpage><lpage>348</lpage><pub-id pub-id-type="doi">10.1016/j.arr.2015.10.002</pub-id><pub-id pub-id-type="pmid">26474742</pub-id></element-citation></ref><ref id="bib56"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Maruyama</surname><given-names>T</given-names></name><name><surname>Mirando</surname><given-names>AJ</given-names></name><name><surname>Deng</surname><given-names>CX</given-names></name><name><surname>Hsu</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2010">2010</year><article-title>The balance of Wnt and FGF signaling influences mesenchymal stem cell fate during skeletal development</article-title><source>Science Signaling</source><volume>3</volume><elocation-id>ra40</elocation-id><pub-id pub-id-type="doi">10.1126/scisignal.2000727</pub-id><pub-id pub-id-type="pmid">20501936</pub-id></element-citation></ref><ref id="bib57"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateos</surname><given-names>J</given-names></name><name><surname>De la Fuente</surname><given-names>A</given-names></name><name><surname>Lesende-Rodriguez</surname><given-names>I</given-names></name><name><surname>Fernández-Pernas</surname><given-names>P</given-names></name><name><surname>Arufe</surname><given-names>MC</given-names></name><name><surname>Blanco</surname><given-names>FJ</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Lamin a deregulation in human mesenchymal stem cells promotes an impairment in their chondrogenic potential and imbalance in their response to oxidative stress</article-title><source>Stem Cell Research</source><volume>11</volume><fpage>1137</fpage><lpage>1148</lpage><pub-id pub-id-type="doi">10.1016/j.scr.2013.07.004</pub-id><pub-id pub-id-type="pmid">23994728</pub-id></element-citation></ref><ref id="bib58"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mateos</surname><given-names>J</given-names></name><name><surname>Fafián-Labora</surname><given-names>J</given-names></name><name><surname>Morente-López</surname><given-names>M</given-names></name><name><surname>Lesende-Rodriguez</surname><given-names>I</given-names></name><name><surname>Monserrat</surname><given-names>L</given-names></name><name><surname>Ódena</surname><given-names>MA</given-names></name><name><surname>Oliveira</surname><given-names>E de</given-names></name><name><surname>de Toro</surname><given-names>J</given-names></name><name><surname>Arufe</surname><given-names>MC</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Next-Generation sequencing and quantitative proteomics of Hutchinson-Gilford progeria syndrome-derived cells point to a role of nucleotide metabolism in premature aging</article-title><source>PLOS ONE</source><volume>13</volume><elocation-id>e0205878</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0205878</pub-id><pub-id pub-id-type="pmid">30379953</pub-id></element-citation></ref><ref id="bib59"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McCord</surname><given-names>RP</given-names></name><name><surname>Nazario-Toole</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Chines</surname><given-names>PS</given-names></name><name><surname>Zhan</surname><given-names>Y</given-names></name><name><surname>Erdos</surname><given-names>MR</given-names></name><name><surname>Collins</surname><given-names>FS</given-names></name><name><surname>Dekker</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>Correlated alterations in genome organization, histone methylation, and DNA-lamin A/C interactions in Hutchinson-Gilford progeria syndrome</article-title><source>Genome Research</source><volume>23</volume><fpage>260</fpage><lpage>269</lpage><pub-id pub-id-type="doi">10.1101/gr.138032.112</pub-id><pub-id pub-id-type="pmid">23152449</pub-id></element-citation></ref><ref id="bib60"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merfeld-Clauss</surname><given-names>S</given-names></name><name><surname>Lease</surname><given-names>BR</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name><name><surname>March</surname><given-names>KL</given-names></name><name><surname>Traktuev</surname><given-names>DO</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Adipose stromal cells differentiation toward smooth muscle cell phenotype diminishes their vasculogenic activity due to induction of activin a secretion</article-title><source>Journal of Tissue Engineering and Regenerative Medicine</source><volume>11</volume><fpage>3145</fpage><lpage>3156</lpage><pub-id pub-id-type="doi">10.1002/term.2223</pub-id><pub-id pub-id-type="pmid">27633499</pub-id></element-citation></ref><ref id="bib61"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Misteli</surname><given-names>T</given-names></name><name><surname>Scaffidi</surname><given-names>P</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Genome instability in progeria: when repair gets old</article-title><source>Nature Medicine</source><volume>11</volume><fpage>718</fpage><lpage>719</lpage><pub-id pub-id-type="doi">10.1038/nm0705-718</pub-id><pub-id pub-id-type="pmid">16015360</pub-id></element-citation></ref><ref id="bib62"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazir</surname><given-names>HM</given-names></name><name><surname>Ramesh Baabhu</surname><given-names>A</given-names></name><name><surname>Muralidharan</surname><given-names>Y</given-names></name><name><surname>Cheppala Rajan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Radiological diagnosis of a rare premature aging genetic disorder: progeria (hutchinson-gilford syndrome)</article-title><source>Case Reports in Radiology</source><volume>2017</volume><elocation-id>1305360</elocation-id><pub-id pub-id-type="doi">10.1155/2017/1305360</pub-id><pub-id pub-id-type="pmid">29138706</pub-id></element-citation></ref><ref id="bib63"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ogata</surname><given-names>S</given-names></name><name><surname>Uhthoff</surname><given-names>HK</given-names></name></person-group><year iso-8601-date="1990">1990</year><article-title>The early development and ossification of the human clavicle -- an embryologic study</article-title><source>Acta Orthopaedica Scandinavica</source><volume>61</volume><fpage>330</fpage><lpage>334</lpage><pub-id pub-id-type="doi">10.3109/17453679008993529</pub-id><pub-id pub-id-type="pmid">2402985</pub-id></element-citation></ref><ref id="bib64"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olsen</surname><given-names>BR</given-names></name><name><surname>Reginato</surname><given-names>AM</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><year iso-8601-date="2000">2000</year><article-title>Bone development</article-title><source>Annual Review of Cell and Developmental Biology</source><volume>16</volume><fpage>191</fpage><lpage>220</lpage><pub-id pub-id-type="doi">10.1146/annurev.cellbio.16.1.191</pub-id><pub-id pub-id-type="pmid">11031235</pub-id></element-citation></ref><ref id="bib65"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozerdem</surname><given-names>U</given-names></name><name><surname>Alitalo</surname><given-names>K</given-names></name><name><surname>Salven</surname><given-names>P</given-names></name><name><surname>Li</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2005">2005</year><article-title>Contribution of bone marrow-derived pericyte precursor cells to corneal vasculogenesis</article-title><source>Investigative Ophthalmology &amp; Visual Science</source><volume>46</volume><fpage>3502</fpage><lpage>3506</lpage><pub-id pub-id-type="doi">10.1167/iovs.05-0309</pub-id><pub-id pub-id-type="pmid">16186326</pub-id></element-citation></ref><ref id="bib66"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pacheco</surname><given-names>LM</given-names></name><name><surname>Gomez</surname><given-names>LA</given-names></name><name><surname>Dias</surname><given-names>J</given-names></name><name><surname>Ziebarth</surname><given-names>NM</given-names></name><name><surname>Howard</surname><given-names>GA</given-names></name><name><surname>Schiller</surname><given-names>PC</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Progerin expression disrupts critical adult stem cell functions involved in tissue repair</article-title><source>Aging</source><volume>6</volume><fpage>1049</fpage><lpage>1063</lpage><pub-id pub-id-type="doi">10.18632/aging.100709</pub-id><pub-id pub-id-type="pmid">25567453</pub-id></element-citation></ref><ref id="bib67"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rauner</surname><given-names>M</given-names></name><name><surname>Sipos</surname><given-names>W</given-names></name><name><surname>Goettsch</surname><given-names>C</given-names></name><name><surname>Wutzl</surname><given-names>A</given-names></name><name><surname>Foisner</surname><given-names>R</given-names></name><name><surname>Pietschmann</surname><given-names>P</given-names></name><name><surname>Hofbauer</surname><given-names>LC</given-names></name></person-group><year iso-8601-date="2009">2009</year><article-title>Inhibition of lamin A/C attenuates osteoblast differentiation and enhances RANKL-dependent osteoclastogenesis</article-title><source>Journal of Bone and Mineral Research</source><volume>24</volume><fpage>78</fpage><lpage>86</lpage><pub-id pub-id-type="doi">10.1359/jbmr.080902</pub-id><pub-id pub-id-type="pmid">18767923</pub-id></element-citation></ref><ref id="bib68"><element-citation publication-type="preprint"><person-group person-group-type="author"><name><surname>Reiff</surname><given-names>SB</given-names></name><name><surname>Schroeder</surname><given-names>AJ</given-names></name><name><surname>Kirli</surname><given-names>K</given-names></name><name><surname>Cosolo</surname><given-names>A</given-names></name><name><surname>Bakker</surname><given-names>C</given-names></name><name><surname>Mercado</surname><given-names>L</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Veit</surname><given-names>AD</given-names></name><name><surname>Balashov</surname><given-names>AK</given-names></name><name><surname>Vitzthum</surname><given-names>C</given-names></name><name><surname>Ronchetti</surname><given-names>W</given-names></name><name><surname>Pitman</surname><given-names>KM</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Ehmsen</surname><given-names>SR</given-names></name><name><surname>Kerpedjiev</surname><given-names>P</given-names></name><name><surname>Abdennur</surname><given-names>N</given-names></name><name><surname>Imakaev</surname><given-names>M</given-names></name><name><surname>Öztürk</surname><given-names>SU</given-names></name><name><surname>Çamoğlu</surname><given-names>U</given-names></name><name><surname>Mirny</surname><given-names>LA</given-names></name><name><surname>Gehlenborg</surname><given-names>N</given-names></name><name><surname>Alver</surname><given-names>BH</given-names></name><name><surname>Park</surname><given-names>PJ</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The 4D Nucleome Data Portal: A Resource for Searching and Visualizing Curated Nucleomics Data</article-title><source>bioRxiv</source><pub-id pub-id-type="doi">10.1101/2021.10.14.464435</pub-id></element-citation></ref><ref id="bib69"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Revêchon</surname><given-names>G</given-names></name><name><surname>Viceconte</surname><given-names>N</given-names></name><name><surname>McKenna</surname><given-names>T</given-names></name><name><surname>Sola Carvajal</surname><given-names>A</given-names></name><name><surname>Vrtačnik</surname><given-names>P</given-names></name><name><surname>Stenvinkel</surname><given-names>P</given-names></name><name><surname>Lundgren</surname><given-names>T</given-names></name><name><surname>Hultenby</surname><given-names>K</given-names></name><name><surname>Franco</surname><given-names>I</given-names></name><name><surname>Eriksson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Rare progerin-expressing preadipocytes and adipocytes contribute to tissue depletion over time</article-title><source>Scientific Reports</source><volume>7</volume><elocation-id>4405</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-017-04492-0</pub-id><pub-id pub-id-type="pmid">28667315</pub-id></element-citation></ref><ref id="bib70"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosengardten</surname><given-names>Y</given-names></name><name><surname>McKenna</surname><given-names>T</given-names></name><name><surname>Grochová</surname><given-names>D</given-names></name><name><surname>Eriksson</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>Stem cell depletion in Hutchinson-Gilford progeria syndrome</article-title><source>Aging Cell</source><volume>10</volume><fpage>1011</fpage><lpage>1020</lpage><pub-id pub-id-type="doi">10.1111/j.1474-9726.2011.00743.x</pub-id><pub-id pub-id-type="pmid">21902803</pub-id></element-citation></ref><ref id="bib71"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>San Martin</surname><given-names>R</given-names></name><name><surname>Barron</surname><given-names>DA</given-names></name><name><surname>Tuxhorn</surname><given-names>JA</given-names></name><name><surname>Ressler</surname><given-names>SJ</given-names></name><name><surname>Hayward</surname><given-names>SW</given-names></name><name><surname>Shen</surname><given-names>X</given-names></name><name><surname>Laucirica</surname><given-names>R</given-names></name><name><surname>Wheeler</surname><given-names>TM</given-names></name><name><surname>Gutierrez</surname><given-names>C</given-names></name><name><surname>Ayala</surname><given-names>GE</given-names></name><name><surname>Ittmann</surname><given-names>M</given-names></name><name><surname>Rowley</surname><given-names>DR</given-names></name></person-group><year iso-8601-date="2014">2014</year><article-title>Recruitment of CD34 (+) fibroblasts in tumor-associated reactive stroma: the reactive microvasculature hypothesis</article-title><source>The American Journal of Pathology</source><volume>184</volume><fpage>1860</fpage><lpage>1870</lpage><pub-id pub-id-type="doi">10.1016/j.ajpath.2014.02.021</pub-id><pub-id pub-id-type="pmid">24713391</pub-id></element-citation></ref><ref id="bib72"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanders</surname><given-names>JT</given-names></name><name><surname>Freeman</surname><given-names>TF</given-names></name><name><surname>Xu</surname><given-names>Y</given-names></name><name><surname>Golloshi</surname><given-names>R</given-names></name><name><surname>Stallard</surname><given-names>MA</given-names></name><name><surname>Hill</surname><given-names>AM</given-names></name><name><surname>San Martin</surname><given-names>R</given-names></name><name><surname>Balajee</surname><given-names>AS</given-names></name><name><surname>McCord</surname><given-names>RP</given-names></name></person-group><year iso-8601-date="2020">2020</year><article-title>Radiation-Induced DNA damage and repair effects on 3D genome organization</article-title><source>Nature Communications</source><volume>11</volume><elocation-id>6178</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-020-20047-w</pub-id><pub-id pub-id-type="pmid">33268790</pub-id></element-citation></ref><ref id="bib73"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>R</given-names></name><name><surname>Zwiesigk</surname><given-names>P</given-names></name><name><surname>Schiborr</surname><given-names>M</given-names></name><name><surname>Schmidt</surname><given-names>S</given-names></name><name><surname>Schmeling</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Ultrasound studies on the time course of clavicular ossification</article-title><source>International Journal of Legal Medicine</source><volume>122</volume><fpage>163</fpage><lpage>167</lpage><pub-id pub-id-type="doi">10.1007/s00414-007-0220-4</pub-id><pub-id pub-id-type="pmid">18180940</pub-id></element-citation></ref><ref id="bib74"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Soundararajan</surname><given-names>M</given-names></name><name><surname>Kannan</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2018">2018</year><article-title>Fibroblasts and mesenchymal stem cells: two sides of the same coin?</article-title><source>Journal of Cellular Physiology</source><volume>233</volume><fpage>9099</fpage><lpage>9109</lpage><pub-id pub-id-type="doi">10.1002/jcp.26860</pub-id><pub-id pub-id-type="pmid">29943820</pub-id></element-citation></ref><ref id="bib75"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traktuev</surname><given-names>DO</given-names></name><name><surname>Merfeld-Clauss</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Kolonin</surname><given-names>M</given-names></name><name><surname>Arap</surname><given-names>W</given-names></name><name><surname>Pasqualini</surname><given-names>R</given-names></name><name><surname>Johnstone</surname><given-names>BH</given-names></name><name><surname>March</surname><given-names>KL</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks</article-title><source>Circulation Research</source><volume>102</volume><fpage>77</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.107.159475</pub-id><pub-id pub-id-type="pmid">17967785</pub-id></element-citation></ref><ref id="bib76"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsukune</surname><given-names>N</given-names></name><name><surname>Naito</surname><given-names>M</given-names></name><name><surname>Ohashi</surname><given-names>A</given-names></name><name><surname>Ninomiya</surname><given-names>T</given-names></name><name><surname>Sato</surname><given-names>S</given-names></name><name><surname>Takahashi</surname><given-names>T</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Forced expression of mouse progerin attenuates the osteoblast differentiation interrupting β-catenin signal pathway in vitro</article-title><source>Cell and Tissue Research</source><volume>375</volume><fpage>655</fpage><lpage>664</lpage><pub-id pub-id-type="doi">10.1007/s00441-018-2930-y</pub-id><pub-id pub-id-type="pmid">30284086</pub-id></element-citation></ref><ref id="bib77"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usami</surname><given-names>Y</given-names></name><name><surname>Gunawardena</surname><given-names>AT</given-names></name><name><surname>Iwamoto</surname><given-names>M</given-names></name><name><surname>Enomoto-Iwamoto</surname><given-names>M</given-names></name></person-group><year iso-8601-date="2016">2016</year><article-title>Wnt signaling in cartilage development and diseases: lessons from animal studies</article-title><source>Laboratory Investigation; a Journal of Technical Methods and Pathology</source><volume>96</volume><fpage>186</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1038/labinvest.2015.142</pub-id><pub-id pub-id-type="pmid">26641070</pub-id></element-citation></ref><ref id="bib78"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wenzel</surname><given-names>V</given-names></name><name><surname>Roedl</surname><given-names>D</given-names></name><name><surname>Gabriel</surname><given-names>D</given-names></name><name><surname>Gordon</surname><given-names>LB</given-names></name><name><surname>Herlyn</surname><given-names>M</given-names></name><name><surname>Schneider</surname><given-names>R</given-names></name><name><surname>Ring</surname><given-names>J</given-names></name><name><surname>Djabali</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2012">2012</year><article-title>Naïve adult stem cells from patients with Hutchinson-Gilford progeria syndrome express low levels of progerin in vivo</article-title><source>Biology Open</source><volume>1</volume><fpage>516</fpage><lpage>526</lpage><pub-id pub-id-type="doi">10.1242/bio.20121149</pub-id><pub-id pub-id-type="pmid">23213444</pub-id></element-citation></ref><ref id="bib79"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wheaton</surname><given-names>K</given-names></name><name><surname>Campuzano</surname><given-names>D</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Sheinis</surname><given-names>M</given-names></name><name><surname>Ho</surname><given-names>B</given-names></name><name><surname>Brown</surname><given-names>GW</given-names></name><name><surname>Benchimol</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2017">2017</year><article-title>Progerin-induced replication stress facilitates premature senescence in Hutchinson-Gilford progeria syndrome</article-title><source>Molecular and Cellular Biology</source><volume>37</volume><elocation-id>e00659-16</elocation-id><pub-id pub-id-type="doi">10.1128/MCB.00659-16</pub-id><pub-id pub-id-type="pmid">28483909</pub-id></element-citation></ref><ref id="bib80"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>M</given-names></name><name><surname>Chagin</surname><given-names>AS</given-names></name></person-group><year iso-8601-date="2021">2021</year><article-title>The epiphyseal secondary ossification center: evolution, development and function</article-title><source>Bone</source><volume>142</volume><elocation-id>115701</elocation-id><pub-id pub-id-type="doi">10.1016/j.bone.2020.115701</pub-id><pub-id pub-id-type="pmid">33091640</pub-id></element-citation></ref><ref id="bib81"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>ZM</given-names></name><name><surname>LaDana</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>D</given-names></name><name><surname>Cao</surname><given-names>K</given-names></name></person-group><year iso-8601-date="2013">2013</year><article-title>An inhibitory role of progerin in the gene induction network of adipocyte differentiation from iPS cells</article-title><source>Aging</source><volume>5</volume><fpage>288</fpage><lpage>303</lpage><pub-id pub-id-type="doi">10.18632/aging.100550</pub-id><pub-id pub-id-type="pmid">23596277</pub-id></element-citation></ref><ref id="bib82"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zannettino</surname><given-names>ACW</given-names></name><name><surname>Paton</surname><given-names>S</given-names></name><name><surname>Arthur</surname><given-names>A</given-names></name><name><surname>Khor</surname><given-names>F</given-names></name><name><surname>Itescu</surname><given-names>S</given-names></name><name><surname>Gimble</surname><given-names>JM</given-names></name><name><surname>Gronthos</surname><given-names>S</given-names></name></person-group><year iso-8601-date="2008">2008</year><article-title>Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo</article-title><source>Journal of Cellular Physiology</source><volume>214</volume><fpage>413</fpage><lpage>421</lpage><pub-id pub-id-type="doi">10.1002/jcp.21210</pub-id><pub-id pub-id-type="pmid">17654479</pub-id></element-citation></ref><ref id="bib83"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Lian</surname><given-names>Q</given-names></name><name><surname>Zhu</surname><given-names>G</given-names></name><name><surname>Zhou</surname><given-names>F</given-names></name><name><surname>Sui</surname><given-names>L</given-names></name><name><surname>Tan</surname><given-names>C</given-names></name><name><surname>Mutalif</surname><given-names>RA</given-names></name><name><surname>Navasankari</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Tse</surname><given-names>H-F</given-names></name><name><surname>Stewart</surname><given-names>CL</given-names></name><name><surname>Colman</surname><given-names>A</given-names></name></person-group><year iso-8601-date="2011">2011</year><article-title>A human iPSC model of Hutchinson Gilford progeria reveals vascular smooth muscle and mesenchymal stem cell defects</article-title><source>Cell Stem Cell</source><volume>8</volume><fpage>31</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/j.stem.2010.12.002</pub-id><pub-id pub-id-type="pmid">21185252</pub-id></element-citation></ref><ref id="bib84"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Parmigiani</surname><given-names>G</given-names></name><name><surname>Johnson</surname><given-names>WE</given-names></name></person-group><year iso-8601-date="2020">2020a</year><article-title>Combat-seq: batch effect adjustment for RNA-seq count data</article-title><source>NAR Genomics and Bioinformatics</source><volume>2</volume><elocation-id>lqaa078</elocation-id><pub-id pub-id-type="doi">10.1093/nargab/lqaa078</pub-id><pub-id pub-id-type="pmid">33015620</pub-id></element-citation></ref><ref id="bib85"><element-citation publication-type="software"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Parmigiani</surname><given-names>G</given-names></name><name><surname>Johnson</surname><given-names>WE</given-names></name></person-group><year iso-8601-date="2020">2020b</year><data-title>ComBat-seq</data-title><source>GitHub</source><ext-link ext-link-type="uri" xlink:href="https://github.com/zhangyuqing/ComBat-seq">https://github.com/zhangyuqing/ComBat-seq</ext-link></element-citation></ref><ref id="bib86"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>Y</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Pache</surname><given-names>L</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Khodabakhshi</surname><given-names>AH</given-names></name><name><surname>Tanaseichuk</surname><given-names>O</given-names></name><name><surname>Benner</surname><given-names>C</given-names></name><name><surname>Chanda</surname><given-names>SK</given-names></name></person-group><year iso-8601-date="2019">2019</year><article-title>Metascape provides a biologist-oriented resource for the analysis of systems-level datasets</article-title><source>Nature Communications</source><volume>10</volume><elocation-id>1523</elocation-id><pub-id pub-id-type="doi">10.1038/s41467-019-09234-6</pub-id><pub-id pub-id-type="pmid">30944313</pub-id></element-citation></ref><ref id="bib87"><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zoetis</surname><given-names>T</given-names></name><name><surname>Tassinari</surname><given-names>MS</given-names></name><name><surname>Bagi</surname><given-names>C</given-names></name><name><surname>Walthall</surname><given-names>K</given-names></name><name><surname>Hurtt</surname><given-names>ME</given-names></name></person-group><year iso-8601-date="2003">2003</year><article-title>Species comparison of postnatal bone growth and development</article-title><source>Birth Defects Research. Part B, Developmental and Reproductive Toxicology</source><volume>68</volume><fpage>86</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1002/bdrb.10012</pub-id><pub-id pub-id-type="pmid">12866701</pub-id></element-citation></ref></ref-list><app-group><app id="appendix-1"><title>Appendix 1</title><p>This appendix includes details on the patients and experimental approaches and statistics for the RNA-seq data and Hi-C data included in this study.</p><table-wrap id="app1table1" position="float"><label>Appendix 1—table 1.</label><caption><title>RNA-seq datasets from progeria patients used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Progeria Patient</th><th align="left" valign="bottom">Age</th><th align="left" valign="bottom">Sex</th><th align="left" valign="bottom">Race</th><th align="left" valign="bottom">RNA-seq approach</th><th align="left" valign="bottom">Lab</th><th align="left" valign="bottom">GEO Series</th></tr></thead><tbody><tr><td align="left" valign="bottom">HGADFN155</td><td align="char" char="." valign="bottom">1 yr 2 mo</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq RNA Sample Preparation v2 protocol)</td><td align="left" valign="bottom">Rodríguez-Paredes</td><td align="left" valign="bottom">GSE150137</td></tr><tr><td align="left" valign="bottom">NG07493</td><td align="char" char="." valign="bottom">2 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">NG11572</td><td align="char" char="." valign="bottom">2 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">HGADFN188</td><td align="char" char="." valign="bottom">2 yr 3 mo</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">HGADFN188</td><td align="char" char="." valign="bottom">2 yr 3 mo</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq RNA Sample Preparation v2 protocol)</td><td align="left" valign="bottom">Rodríguez-Paredes</td><td align="left" valign="bottom">GSE150137</td></tr><tr><td align="left" valign="bottom">HGADFN367</td><td align="char" char="." valign="bottom">3 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">NG06917</td><td align="char" char="." valign="bottom">3 yr</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">HGADFN127</td><td align="char" char="." valign="bottom">3 yr 9 mo</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">NG10677</td><td align="char" char="." valign="bottom">4 yr</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">HGADFN164</td><td align="char" char="." valign="bottom">4 yr 8 mo</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">HGADFN164</td><td align="char" char="." valign="bottom">4 yr 8 mo</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq RNA Sample Preparation v2 protocol)</td><td align="left" valign="bottom">Rodríguez-Paredes</td><td align="left" valign="bottom">GSE150137</td></tr><tr><td align="left" valign="bottom">HGADFN122</td><td align="char" char="." valign="bottom">5 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">HGADFN178</td><td align="char" char="." valign="bottom">6 yr 11 mo</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG11513</td><td align="char" char="." valign="bottom">8 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">NG08466</td><td align="char" char="." valign="bottom">8 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">NG11513</td><td align="char" char="." valign="bottom">8 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">HGADFN167</td><td align="char" char="." valign="bottom">8 yr 5 mo</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (NEBNext Ultra DNA Library Prep Kit)</td><td align="left" valign="bottom">Ikegami</td><td align="left" valign="bottom">GSE113343</td></tr><tr><td align="left" valign="bottom">HGADFN167-2</td><td align="char" char="." valign="bottom">8 yr 5 mo</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (NEBNext Ultra DNA Library Prep Kit)</td><td align="left" valign="bottom">Ikegami</td><td align="left" valign="bottom">GSE113343</td></tr><tr><td align="left" valign="bottom">HGADFN167</td><td align="char" char="." valign="bottom">8 yr 5 mo</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">HGADFN167</td><td align="char" char="." valign="bottom">8 yr 5 mo</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq RNA Sample Preparation v2 protocol)</td><td align="left" valign="bottom">Rodríguez-Paredes</td><td align="left" valign="bottom">GSE150137</td></tr><tr><td align="left" valign="bottom">HGADFN169</td><td align="char" char="." valign="bottom">8 yr 6 mo</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">HGADFN169</td><td align="char" char="." valign="bottom">8 yr 6 mo</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq RNA Sample Preparation v2 protocol)</td><td align="left" valign="bottom">Rodríguez-Paredes</td><td align="left" valign="bottom">GSE150137</td></tr><tr><td align="left" valign="bottom">HGADFN143</td><td align="char" char="." valign="bottom">8 yr 10 mo</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">HGADFN143</td><td align="char" char="." valign="bottom">8 yr 10 mo</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq RNA Sample Preparation v2 protocol)</td><td align="left" valign="bottom">Rodríguez-Paredes</td><td align="left" valign="bottom">GSE150137</td></tr><tr><td align="left" valign="bottom">AG03199</td><td align="char" char="." valign="bottom">10 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (Illumina SureSelect Strand Specific RNA library Prep)</td><td align="left" valign="bottom">Arufe</td><td align="left" valign="bottom">GSE113648</td></tr><tr><td align="left" valign="bottom">NG03198</td><td align="char" char="." valign="bottom">10 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">AG03513</td><td align="char" char="." valign="bottom">13 yr</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White Mexican</td><td align="left" valign="bottom">polyA (Illumina SureSelect Strand Specific RNA library Prep)</td><td align="left" valign="bottom">Arufe</td><td align="left" valign="bottom">GSE113648</td></tr><tr><td align="left" valign="bottom">AG11498</td><td align="char" char="." valign="bottom">14 yr</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">African American</td><td align="left" valign="bottom">polyA (NEBNext Ultra DNA Library Prep Kit)</td><td align="left" valign="bottom">Ikegami</td><td align="left" valign="bottom">GSE113343</td></tr><tr><td align="left" valign="bottom">AG11498-2</td><td align="char" char="." valign="bottom">14 yr</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">African American</td><td align="left" valign="bottom">polyA (NEBNext Ultra DNA Library Prep Kit)</td><td align="left" valign="bottom">Ikegami</td><td align="left" valign="bottom">GSE113343</td></tr><tr><td align="left" valign="bottom">NA01972</td><td align="char" char="." valign="bottom">14 yr</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">NG10578</td><td align="char" char="." valign="bottom">17 yr</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">NA01178</td><td align="char" char="." valign="bottom">20 yr</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr><tr><td align="left" valign="bottom">NG01178</td><td align="char" char="." valign="bottom">20 yr</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">rRNA depletion</td><td align="left" valign="bottom">McCord</td><td align="left" valign="bottom">GSE206684</td></tr></tbody></table></table-wrap><table-wrap id="app1table2" position="float"><label>Appendix 1—table 2.</label><caption><title>RNA-seq datasets from adult controls used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Donor</th><th align="left" valign="bottom">Age</th><th align="left" valign="bottom">Sex</th><th align="left" valign="bottom">Race</th><th align="left" valign="bottom">RNA-seq approach</th><th align="left" valign="bottom">Lab</th><th align="left" valign="bottom">GEO Series</th></tr><tr><th align="left" valign="bottom" colspan="7"><italic>Parent of Progeria Patient</italic></th></tr></thead><tbody><tr><td align="left" valign="bottom">AG03257</td><td align="char" char="." valign="bottom">35</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom"/><td align="left" valign="bottom">polyA (Illumina SureSelect Strand Specific RNA library Prep)</td><td align="left" valign="bottom">Arufe</td><td align="left" valign="bottom">GSE113648</td></tr><tr><td align="left" valign="bottom">AG03512</td><td align="char" char="." valign="bottom">41</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom"/><td align="left" valign="bottom">polyA (Illumina SureSelect Strand Specific RNA library Prep)</td><td align="left" valign="bottom">Arufe</td><td align="left" valign="bottom">GSE113648</td></tr><tr><th align="left" valign="bottom" colspan="7"><italic>Healthy Mid-Age Adult</italic></th></tr><tr><td align="left" valign="bottom">AG07124</td><td align="char" char="." valign="bottom">26</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM00495</td><td align="char" char="." valign="bottom">29</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG07478</td><td align="char" char="." valign="bottom">29</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG04054</td><td align="char" char="." valign="bottom">29</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG09599</td><td align="char" char="." valign="bottom">30</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG09605</td><td align="char" char="." valign="bottom">30</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM04503</td><td align="char" char="." valign="bottom">31</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM04504</td><td align="char" char="." valign="bottom">31</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM00043</td><td align="char" char="." valign="bottom">32</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Black, Puerto Rican</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM01650</td><td align="char" char="." valign="bottom">37</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM01717</td><td align="char" char="." valign="bottom">39</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG16358</td><td align="char" char="." valign="bottom">41</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG13967</td><td align="char" char="." valign="bottom">41</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG04063</td><td align="char" char="." valign="bottom">43</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><th align="left" valign="bottom" colspan="7"><italic>Older Adult Control</italic></th></tr><tr><td align="left" valign="bottom">GM03525</td><td align="char" char="." valign="bottom">80</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM01706</td><td align="char" char="." valign="bottom">82</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG04386</td><td align="char" char="." valign="bottom">83</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG11744</td><td align="char" char="." valign="bottom">84</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG11725</td><td align="char" char="." valign="bottom">84</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG05274</td><td align="char" char="." valign="bottom">84</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG05247</td><td align="char" char="." valign="bottom">87</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG04662</td><td align="char" char="." valign="bottom">87</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG13129</td><td align="char" char="." valign="bottom">89</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG12788</td><td align="char" char="." valign="bottom">90</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG07725</td><td align="char" char="." valign="bottom">91</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG09602</td><td align="char" char="." valign="bottom">92</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG04064</td><td align="char" char="." valign="bottom">92</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG08433</td><td align="char" char="." valign="bottom">94</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG04059</td><td align="char" char="." valign="bottom">96</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">White</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr></tbody></table></table-wrap><table-wrap id="app1table3" position="float"><label>Appendix 1—table 3.</label><caption><title>RNA-seq datasets from children controls used in this study.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Healthy Child</th><th align="left" valign="bottom">Age</th><th align="left" valign="bottom">Sex</th><th align="left" valign="bottom">Race</th><th align="left" valign="bottom">RNA-seq approach</th><th align="left" valign="bottom">Lab</th><th align="left" valign="bottom">GEO Series</th></tr></thead><tbody><tr><td align="left" valign="bottom">AG08498</td><td align="char" char="." valign="bottom">1</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Asian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM00969</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM00969</td><td align="char" char="." valign="bottom">2</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq RNA Sample Preparation v2 protocol)</td><td align="left" valign="bottom">Rodríguez-Paredes</td><td align="left" valign="bottom">GSE150137</td></tr><tr><td align="left" valign="bottom">GM05565</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Latino/Hispanic</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM00498</td><td align="char" char="." valign="bottom">3</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM05400</td><td align="char" char="." valign="bottom">6</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Black</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM00409</td><td align="char" char="." valign="bottom">7</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM00499</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM08398</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (NEBNext Ultra DNA Library Prep Kit)</td><td align="left" valign="bottom">Ikegami</td><td align="left" valign="bottom">GSE113343</td></tr><tr><td align="left" valign="bottom">GM08398-2</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (NEBNext Ultra DNA Library Prep Kit)</td><td align="left" valign="bottom">Ikegami</td><td align="left" valign="bottom">GSE113343</td></tr><tr><td align="left" valign="bottom">GM08398</td><td align="char" char="." valign="bottom">8</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM00038</td><td align="char" char="." valign="bottom">9</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Black</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM01652</td><td align="char" char="." valign="bottom">11</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM01582</td><td align="char" char="." valign="bottom">11</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">AG16409</td><td align="char" char="." valign="bottom">12</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM07532</td><td align="char" char="." valign="bottom">16</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Unknown</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM07753</td><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM07492</td><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (NEBNext Ultra DNA Library Prep Kit)</td><td align="left" valign="bottom">Ikegami</td><td align="left" valign="bottom">GSE113343</td></tr><tr><td align="left" valign="bottom">GM07492-2</td><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (NEBNext Ultra DNA Library Prep Kit)</td><td align="left" valign="bottom">Ikegami</td><td align="left" valign="bottom">GSE113343</td></tr><tr><td align="left" valign="bottom">GM07492</td><td align="char" char="." valign="bottom">17</td><td align="left" valign="bottom">M</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr><tr><td align="left" valign="bottom">GM08399</td><td align="char" char="." valign="bottom">19</td><td align="left" valign="bottom">F</td><td align="left" valign="bottom">Caucasian</td><td align="left" valign="bottom">polyA (TruSeq Stranded mRNA)</td><td align="left" valign="bottom">Fleischer</td><td align="left" valign="bottom">GSE113957</td></tr></tbody></table></table-wrap><table-wrap id="app1table4" position="float"><label>Appendix 1—table 4.</label><caption><title>Hi-C Data Statistics.</title></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" valign="bottom">Sample Name</th><th align="left" valign="bottom">Enzyme</th><th align="left" valign="bottom">Genotype</th><th align="left" valign="bottom">Gender, Age</th><th align="left" valign="bottom">Raw Reads</th><th align="left" valign="bottom">Both Sides Mapped</th><th align="left" valign="bottom">% Map</th><th align="left" valign="bottom">% Dangling Ends</th><th align="left" valign="bottom">Valid Pairs</th><th align="left" valign="bottom">Unique Valid Pairs</th><th align="left" valign="bottom">%Cis</th></tr></thead><tbody><tr><td align="left" valign="bottom">Progeria-167-DpnII-P19-R1</td><td align="left" valign="bottom">DpnII</td><td align="left" valign="bottom">HGPS</td><td align="left" valign="bottom">Male, 8Y</td><td align="char" char="." valign="bottom">364,961,495</td><td align="char" char="." valign="bottom">220,942,665</td><td align="char" char="." valign="bottom">60.5</td><td align="char" char="." valign="bottom">3.05</td><td align="char" char="." valign="bottom">208,963,277</td><td align="char" char="." valign="bottom">152,974,533</td><td align="char" char="." valign="bottom">54.69</td></tr><tr><td align="left" valign="bottom">Progeria-168-DpnII-P16-R1</td><td align="left" valign="bottom">DpnII</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">Male, 40Y</td><td align="char" char="." valign="bottom">358,703,556</td><td align="char" char="." valign="bottom">220,880,406</td><td align="char" char="." valign="bottom">61.6</td><td align="char" char="." valign="bottom">3.48</td><td align="char" char="." valign="bottom">212,152,596</td><td align="char" char="." valign="bottom">148,022,234</td><td align="char" char="." valign="bottom">54.98</td></tr><tr><td align="left" valign="bottom">Progeria-AG03257-P7-R1</td><td align="left" valign="bottom">DpnII</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">Female, 35Y</td><td align="char" char="." valign="bottom">274,364,560</td><td align="char" char="." valign="bottom">177,877,476</td><td align="char" char="." valign="bottom">64.8</td><td align="char" char="." valign="bottom">0.95</td><td align="char" char="." valign="bottom">174,730,268</td><td align="char" char="." valign="bottom">132,694,872</td><td align="char" char="." valign="bottom">49.65</td></tr><tr><td align="left" valign="bottom">Progeria-AG03257-P7-R3</td><td align="left" valign="bottom">DpnII</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">Female, 35Y</td><td align="char" char="." valign="bottom">127,656,906</td><td align="char" char="." valign="bottom">73,190,497</td><td align="char" char="." valign="bottom">57.3</td><td align="char" char="." valign="bottom">2.26</td><td align="char" char="." valign="bottom">70,541,316</td><td align="char" char="." valign="bottom">46,463,429</td><td align="char" char="." valign="bottom">83.56</td></tr><tr><td align="left" valign="bottom">Progeria-AG11513-P7-R1</td><td align="left" valign="bottom">DpnII</td><td align="left" valign="bottom">HGPS</td><td align="left" valign="bottom">Female, 8Y</td><td align="char" char="." valign="bottom">251,483,696</td><td align="char" char="." valign="bottom">154,772,051</td><td align="char" char="." valign="bottom">61.5</td><td align="char" char="." valign="bottom">0.46</td><td align="char" char="." valign="bottom">153,219,873</td><td align="char" char="." valign="bottom">116,077,671</td><td align="char" char="." valign="bottom">48.77</td></tr><tr><td align="left" valign="bottom">Progeria-AG11513-P7-R2</td><td align="left" valign="bottom">DpnII</td><td align="left" valign="bottom">HGPS</td><td align="left" valign="bottom">Female, 8Y</td><td align="char" char="." valign="bottom">251,776,055</td><td align="char" char="." valign="bottom">153,160,225</td><td align="char" char="." valign="bottom">60.8</td><td align="char" char="." valign="bottom">0.75</td><td align="char" char="." valign="bottom">151,305,617</td><td align="char" char="." valign="bottom">114,631,955</td><td align="char" char="." valign="bottom">50.22</td></tr><tr><td align="left" valign="bottom">Progeria-HGADFN167-P12-R1</td><td align="left" valign="bottom">HindIII</td><td align="left" valign="bottom">HGPS</td><td align="left" valign="bottom">Male, 8Y</td><td align="char" char="." valign="bottom">165,040,682</td><td align="char" char="." valign="bottom">116,708,094</td><td align="char" char="." valign="bottom">70.7</td><td align="char" char="." valign="bottom">24.91</td><td align="char" char="." valign="bottom">86,987,628</td><td align="char" char="." valign="bottom">81,047,934</td><td align="char" char="." valign="bottom">67.32</td></tr><tr><td align="left" valign="bottom">Progeria-HGADFN167-P19-R1</td><td align="left" valign="bottom">HindIII</td><td align="left" valign="bottom">HGPS</td><td align="left" valign="bottom">Male, 8Y</td><td align="char" char="." valign="bottom">202,090,523</td><td align="char" char="." valign="bottom">136,172,100</td><td align="char" char="." valign="bottom">67.4</td><td align="char" char="." valign="bottom">14.12</td><td align="char" char="." valign="bottom">116,222,620</td><td align="char" char="." valign="bottom">95,537,352</td><td align="char" char="." valign="bottom">82.72</td></tr><tr><td align="left" valign="bottom">Progeria-HGADFN168-P12-R1</td><td align="left" valign="bottom">HindIII</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">Male, 40Y</td><td align="char" char="." valign="bottom">194,414,002</td><td align="char" char="." valign="bottom">136,139,915</td><td align="char" char="." valign="bottom">70.0</td><td align="char" char="." valign="bottom">16.61</td><td align="char" char="." valign="bottom">112,990,317</td><td align="char" char="." valign="bottom">77,889,695</td><td align="char" char="." valign="bottom">81.23</td></tr><tr><td align="left" valign="bottom">Progeria-HGADFN168-P27-R1</td><td align="left" valign="bottom">HindIII</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">Male, 40Y</td><td align="char" char="." valign="bottom">157,637,031</td><td align="char" char="." valign="bottom">110,558,519</td><td align="char" char="." valign="bottom">70.1</td><td align="char" char="." valign="bottom">15.06</td><td align="char" char="." valign="bottom">93,504,712</td><td align="char" char="." valign="bottom">86,842,660</td><td align="char" char="." valign="bottom">67.32</td></tr><tr><td align="left" valign="bottom">Progeria-GM08398-P13-R1</td><td align="left" valign="bottom">Arima</td><td align="left" valign="bottom">WT</td><td align="left" valign="bottom">Male, 8Y</td><td align="char" char="." valign="bottom">475,221,692</td><td align="char" char="." valign="bottom">309,944,409</td><td align="char" char="." valign="bottom">65.2</td><td align="char" char="." valign="bottom">1.59</td><td align="char" char="." valign="bottom">301,485,345</td><td align="char" char="." valign="bottom">182,322,975</td><td align="char" char="." valign="bottom">83.07</td></tr></tbody></table></table-wrap></app></app-group></back><sub-article article-type="editor-report" id="sa0"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81290.sa0</article-id><title-group><article-title>Editor's evaluation</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Ackert-Bicknell</surname><given-names>Cheryl</given-names></name><role specific-use="editor">Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jc20583</institution-id><institution>University of Colorado</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group><related-object id="sa0ro1" object-id-type="id" object-id="10.1101/2022.06.21.497024" link-type="continued-by" xlink:href="https://sciety.org/articles/activity/10.1101/2022.06.21.497024"/></front-stub><body><p>This manuscript is of interest to researchers investigating genetic mechanisms of aging and transcriptional regulation of developmental processes in mesenchyme-derived tissues. In this study, fibroblast cell lines from patients with and without Hutchinson-Gilford Progeria were compared to pinpoint the molecular mechanisms leading to the phenotypes of persons with this condition. The identification of five major dysregulated functional hubs in fibroblast cell lines derived from Hutchinson-Gilford Progeria Syndrome (HGPS) patients provides a unique opportunity for others working on this disorder to utilize animal models to validate the authors' hypotheses.</p></body></sub-article><sub-article article-type="decision-letter" id="sa1"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81290.sa1</article-id><title-group><article-title>Decision letter</article-title></title-group><contrib-group content-type="section"><contrib contrib-type="editor"><name><surname>Ackert-Bicknell</surname><given-names>Cheryl</given-names></name><role>Reviewing Editor</role><aff><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00jc20583</institution-id><institution>University of Colorado</institution></institution-wrap><country>United States</country></aff></contrib></contrib-group></front-stub><body><boxed-text id="sa2-box1"><p>Our editorial process produces two outputs: (i) <ext-link ext-link-type="uri" xlink:href="https://sciety.org/articles/activity/10.1101/2022.06.21.497024">public reviews</ext-link> designed to be posted alongside <ext-link ext-link-type="uri" xlink:href="https://www.biorxiv.org/content/10.1101/2022.06.21.497024v1">the preprint</ext-link> for the benefit of readers; (ii) feedback on the manuscript for the authors, including requests for revisions, shown below. We also include an acceptance summary that explains what the editors found interesting or important about the work.</p></boxed-text><p><bold>Decision letter after peer review:</bold></p><p>Thank you for submitting your article &quot;Transcriptional profiling of Hutchinson-Gilford Progeria syndrome fibroblasts reveals deficits in mesenchymal stem cell commitment to differentiation related to early events in endochondral ossification&quot; for consideration by <italic>eLife</italic>. Your article has been reviewed by 2 peer reviewers, one of whom is a member of our Board of Reviewing Editors, and the evaluation has been overseen by Carlos Isales as the Senior Editor. The reviewers have opted to remain anonymous.</p><p>The reviewers have discussed their reviews with one another, and the Reviewing Editor has drafted this to help you prepare a revised submission.</p><p>Essential revisions:</p><p>1. There is no conclusion to this paper and one needs to be added. The speculations at the end of the discussion are interesting but not tied into the rest of the narrative. The discussion as it exists is a series of speculations built on preceding speculations, all derived from previously published studies. While this reviewer appreciates the attempt to fit this study's findings into a current paradigm that hypothesizes stem cell depletion as a pathomechanism in HGPS, there is no direct evidence to support that hypothesis in this study, especially as it applies to endochondral ossification. Although it is beyond the scope of the current study, one potential approach to address this would be to experimentally quantitate MSCs in different tissue compartments at multiple timepoints during an HGPS animal model's lifespan.</p><p>2. The abstract is just a series of “what was done” statements and is not effective at highlighting the main findings and take-home conclusion.</p><p>3. The sample set needs to be more completely described up front in this paper (what are the patient demographics of the final data set). This is available to a certain extent but you really need to dig for it. Further, it needs to be clearly stated that these cells were never differentiated into mesenchymal stem cells.</p><p>4. The cartoon at the top of the figuring to denote the focus of that figure is less effective than just stating in words in a title what that figure is about.</p><p>5. The father-son data is interesting but this is an n of one pair and needs to be replicated to support the conclusions made. Barring the availability of additional data, this section needs to be either removed or less importance given to these results.</p><p>6. Tables 1 and 2 are missing from the manuscript and must be included in the future version.</p><p>7. The authors state that their transcriptional analysis reveals eight clusters of altered biological activity in HGPS, but it is not entirely clear what those eight specific clusters are based on the way the section is written.</p><p>8. Figure 2C: why was the age-matched control comparison throughout this manuscript excluded from this particular analysis?</p><p>9. The 10th paragraph of the Results, pertaining to epigenetic modifications, seems more suited to be presented earlier in the section where the authors present their GO analysis highlighting epigenetic programming and DNA maintenance (3rd paragraph of Results) with regards to Figure 1.</p><p>10. 11th paragraph: The underlying theme of the manuscript is that defective mesenchymal stem cell commitment in HGPS results in abnormal development of bone. As such, the gene expression data related to ossification and calcium homeostasis should be provided. Furthermore, BMP4 stated to be upregulated, is not included in the heat plot associated with this finding (Figure 7A).</p><p>11. Downregulated genes are shown to be associated with alterations in compartment identity or lamin interactions. There is no mention if similar alterations occur for upregulated genes, which should be included.</p><p>12. Some important findings in this study include the dysregulation of pathways involved in blood vessel morphogenesis and maturation, muscle development, and lipid metabolism. Vascularization is essential for normal bone development and tissue, muscle provides mechanical and metabolic influences on bone homeostasis, while lipid metabolism is critical in determining the phenotypic fate of common progenitors of osteoblasts and adipocytes. The authors should therefore comment on the potential roles dysregulation of these pathways has in the HGPS bone phenotype as an alternative to suggesting MSC depletion as the sole driving force behind HGPS pathology.</p><p>13. A major shortcoming of this work is the drawing of conclusions on pathomechanisms of HGPS in multiple mesenchyme-derived tissues based on fibroblast transcriptional and epigenetic profiles which are, however, acknowledged by the authors. Specifically, changes in gene expression are attributed to alterations in compartment identity or lamina association in fibroblasts, but no data is provided to suggest those same changes occur identically in other cells or tissues where conclusions are being made. This requires further discussion in the paper.</p><p>14. The manuscript would be strengthened by reorganizing the Results section to more clearly present the data pertaining to each of the five functional hubs that were found to be affected in HGPS cell lines in a linear manner.</p></body></sub-article><sub-article article-type="reply" id="sa2"><front-stub><article-id pub-id-type="doi">10.7554/eLife.81290.sa2</article-id><title-group><article-title>Author response</article-title></title-group></front-stub><body><disp-quote content-type="editor-comment"><p>Essential revisions:</p><p>1. There is no conclusion to this paper and one needs to be added. The speculations at the end of the discussion are interesting but not tied into the rest of the narrative. The discussion as it exists is a series of speculations built on preceding speculations, all derived from previously published studies. While this reviewer appreciates the attempt to fit this study's findings into a current paradigm that hypothesizes stem cell depletion as a pathomechanism in HGPS, there is no direct evidence to support that hypothesis in this study, especially as it applies to endochondral ossification. Although it is beyond the scope of the current study, one potential approach to address this would be to experimentally quantitate MSCs in different tissue compartments at multiple timepoints during an HGPS animal model's lifespan.</p></disp-quote><p>The first section of the Discussion describes our conclusions that can be drawn directly from the data and analyses that we have presented in this study. To clarify and reiterate these more direct conclusions, we have now included a brief final “Conclusion” paragraph with a heading at the very end of the paper, after the ideas and speculation.</p><p>We are glad that the reviewers see value in our efforts to place our results in the context of broader hypotheses about Progeria pathogenesis. Our study builds on the clinical observations of deficits in endochondral ossification in progeria patients, seen in the regression of terminal phalanges and lack of fusion in the clavicle in adolescent patients. Our results provide insights into potential misregulated targets related to these events which we find correlate with the specific ages at which these developmental processes occur. We agree that these results do not provide specific evidence that these genes underlie the deficits seen in patients and that more work is needed to test that idea. We agree that animal studies are beyond the scope of the current study, and we hope that the timely publication of the present analysis will inform the field, and other progeria researchers with access to those animal models, to conduct those types of experiments. We have taken care in the revision to clarify wherever possible what we can conclude directly from our data vs. what is a hypothesis for the future.</p><disp-quote content-type="editor-comment"><p>2. The abstract is just a series of “what was done” statements and is not effective at highlighting the main findings and take-home conclusion.</p></disp-quote><p>We have now revised the abstract to highlight the findings more clearly.</p><disp-quote content-type="editor-comment"><p>3. The sample set needs to be more completely described up front in this paper (what are the patient demographics of the final data set). This is available to a certain extent but you really need to dig for it. Further, it needs to be clearly stated that these cells were never differentiated into mesenchymal stem cells.</p></disp-quote><p>We have modified our RNA-seq sample tables to more clearly present the demographics of all patients and controls included in the final datasets, including both the new RNA-seq data we generated and previously published datasets (Appendix 1 – Tables 1-3). These tables are referenced in the Methods section. We have also included more of this information directly in the manuscript as shown below:</p><p>“In this study, we conduct a comprehensive analysis of previously published RNA-seq datasets for HPGS fibroblast lines harboring the typical C&gt;T mutation in the LMNA gene and provide transcriptomics data for nine previously unreported cell lines. By comparing the transcriptional profile of HPGS fibroblasts (33 datasets, 21 patients, 1-20 years old) with fibroblasts derived from age-matched controls (21 datasets, 16 donors, 1-19 years old), healthy adults, (16 donors, 26-43 years old) and healthy old adults (15 donors, 80-96 years old), we provide insight into important defects in repair biology, metabolism (calcium, lipid), and other areas of mesenchymal cell lineage importance.”</p><p>Changes have been made to the manuscript to clarify that these fibroblasts were not induced to any of the lineages as follows:</p><p>“In this analysis of fibroblasts, we also identified misregulation of gene targets typically associated with the biology of mesenchymal tissue. Specifically, we see misregulation of transcription of genes involved in bone (165 genes. Figure 3),”</p><p>We have revised text in other places to remind the reader that our conclusions are drawn from fibroblasts rather than other mentioned cell types, such as in the introduction:</p><p>“Our results show that transcription of genes involved in negative regulation of chondrocyte commitment are compromised in fibroblasts from patients that are at the age of onset of postnatal endochondral ossification.”</p><disp-quote content-type="editor-comment"><p>4. The cartoon at the top of the figuring to denote the focus of that figure is less effective than just stating in words in a title what that figure is about.</p></disp-quote><p>We have now added titles to all figures for further clarity, though we also still include the cartoons to cater to more visual readers.</p><disp-quote content-type="editor-comment"><p>5. The father-son data is interesting but this is an n of one pair and needs to be replicated to support the conclusions made. Barring the availability of additional data, this section needs to be either removed or less importance given to these results.</p></disp-quote><p>We attempted to collect an additional parent-child matched pair-- the mother AG03257 sample we have is matched to a Progeria patient fibroblast line AG0199, but this particular Progeria patient’s cells enter senescence so quickly in culture that we could not collect enough cells for a Hi-C experiment. Generally, matched pairs are very limited in their availability. We include the conclusions we present for comparison to previous work (McCord et al., 2013) but we have toned down the language so as not to emphasize the “matched pair” nature of the comparison too much.</p><disp-quote content-type="editor-comment"><p>6. Tables 1 and 2 are missing from the manuscript and must be included in the future version.</p></disp-quote><p>We apologize for this oversight and have now included the tables.</p><disp-quote content-type="editor-comment"><p>7. The authors state that their transcriptional analysis reveals eight clusters of altered biological activity in HGPS, but it is not entirely clear what those eight specific clusters are based on the way the section is written.</p></disp-quote><p>Clarification of the specific clusters was added in the result section under “Gene ontology analysis of transcriptional changes reveals eight clusters of biological activity affected in HGPS”, in the second paragraph as follows:</p><p>“Overall, relevant gene ontology terms identified in the study pertain to eight functional clusters: DNA maintenance and Epigenetics (figure 1), Repair and Extracellular matrix (figure 2), Bone (figure 3), Adipose Tissue (figure 4), Blood Vessels (figure 5), and Muscle (figure 6)”</p><disp-quote content-type="editor-comment"><p>8. Figure 2C: why was the age-matched control comparison throughout this manuscript excluded from this particular analysis?</p></disp-quote><p>The age-matched control comparison was not excluded from this analysis. Instead, as shown in the heatmaps, there is no significant enrichment in these pathways in the age-matched controls. Rather, these effects are observed in comparisons with older control cohorts, which were the only ones included in the results table for clarity.</p><p>We have now clarified this in the figure legend as follows:</p><p>Figure 2</p><p>A) Heat map of RNA-seq transcriptome analysis for 585 selected genes related to repair. Data presented as in Figure 1B.</p><p>B) Heat map of RNA-seq transcriptome analysis for 145 selected genes related to extra cellular matrix. Data presented as in Figure 1B.</p><p>C) Summary table of processes related to repair and extra cellular matrix organization, represented as up or downregulation in transcription based on RNA-seq of young/teenager progeria patient derived fibroblasts, compared to middle age or old control patients. Age comparisons that yielded no significant results in relevant categories are not shown</p><disp-quote content-type="editor-comment"><p>9. The 10th paragraph of the Results, pertaining to epigenetic modifications, seems more suited to be presented earlier in the section where the authors present their GO analysis highlighting epigenetic programming and DNA maintenance (3rd paragraph of Results) with regards to Figure 1.</p></disp-quote><p>We apologize for the confusion, but this paragraph refers to a different analysis with further age stratification, as stated in the previous paragraph: “To further refine our findings related to young age patients and the mesenchymal phenotypes observed, we stratified the young HGPS patients into two age groups: early infancy (0-3 years old) and children (4-7 years old)”. We go on to describe (a) total number of genes that appear up and down-regulated, (b) the similarity of the HDAC GO terms in the 0-3 y/o cohort with the previous analysis, and finally (c) the differences observed in the 4–7-year-old cohort, where “ten percent are related to chondrogenesis events”, along with the genes identified.</p><disp-quote content-type="editor-comment"><p>10. 11th paragraph: The underlying theme of the manuscript is that defective mesenchymal stem cell commitment in HGPS results in abnormal development of bone. As such, the gene expression data related to ossification and calcium homeostasis should be provided. Furthermore, BMP4 stated to be upregulated, is not included in the heat plot associated with this finding (Figure 7A).</p></disp-quote><p>The bone-related genes that are found in the initial full comparison of all HGPS patients vs. controls are highlighted in Figure 3. This set actually includes BMP4, but there are too many genes in that figure to call out by name. Then, figure 7 shows additional endochondral ossification genes found specifically in the comparisons where Progeria patients were stratified by age. This includes WNT5a and many of its pathway targets, as highlighted in Figure 7a/b. We have now added a detailed examination of BMP4 expression in Figure 7c in order to highlight this comparison as well in this figure. We have also focused on the Hi-C data of BMP4 in Figure 9, adding to the coherence of the flow of the results.</p><p>Gene expression data related to ossification and calcium homeostasis (Zscore tables AND/OR gene counts tables, by patient, are also now provided in Figure 3, Source Data 1)</p><disp-quote content-type="editor-comment"><p>11. Downregulated genes are shown to be associated with alterations in compartment identity or lamin interactions. There is no mention if similar alterations occur for upregulated genes, which should be included.</p></disp-quote><p>The upregulated gene compartment comparison is shown in Figure 8F-H as well- the left panel of each set is upregulated and the right is downregulated. We agree that this was not clearly labeled in the figure and we have now added upregulated and downregulated headers over the plots for clarity as well as titles indicating which comparisons each panel shows. These graphs show that upregulated genes do not show a corresponding shift in compartment, so this is an effect specific to downregulated genes overall. We have now more clearly stated this in the text.</p><disp-quote content-type="editor-comment"><p>12. Some important findings in this study include the dysregulation of pathways involved in blood vessel morphogenesis and maturation, muscle development, and lipid metabolism. Vascularization is essential for normal bone development and tissue, muscle provides mechanical and metabolic influences on bone homeostasis, while lipid metabolism is critical in determining the phenotypic fate of common progenitors of osteoblasts and adipocytes. The authors should therefore comment on the potential roles dysregulation of these pathways has in the HGPS bone phenotype as an alternative to suggesting MSC depletion as the sole driving force behind HGPS pathology.</p></disp-quote><p>Our manuscript revisions attempt to clarify that we do not intend to claim that MSC depletion is the only driving force behind HGPS pathology. The reviewers are correct that each of these pathways and tissues can influence each other, and thus we have included statements that we observe gene misregulation across multiple mesenchymal lineage pathways.</p><p>We include a discussion of the potential relationship between vascular function and adipogenesis in the discussion paragraph which begins “Related to later differentiation events, the depletion of microvasculature…”</p><p>However, taking into account other reviewer recommendations, we also have revised the manuscript to ensure it is clear that everything we are measuring here is derived from what can be detected in fibroblasts. Fibroblasts can be a sentinel of mesenchymal lineage health in chronic disease and fibroblast samples from patients can include MSCs, therefore, we think speculating on the MSC pool is possible, but it would be overreaching to use fibroblast data to draw too many conclusions about vascularization and muscle mechanics in bone development.</p><p>We have changed the ideas and speculation section to address some of these concerns and to make the claims “softer”</p><p>Ideas and speculation</p><p>Overall, the cohorts of biological processes that we observe to be misregulated across different age groups of Progeria patients lead us to speculate the impact of this misregulation across a series of events in development, which will warrant further investigation:</p><p>A. Biology of priority: the formation of bone “fires” at specific times. These events are “non-negotiable” potentially taking precedence over other concomitant MSC fates. Deficits in endochondral ossification will condition the system to drawing from pericyte and tissue-resident MSCs in an attempt to compensate.</p><p>B. The loss of bone fusion and regression of bone length observed in teenaged HGPS patients is an indirect result of deficits in arrest of chondrogenesis proliferation, that occurred in early childhood. These deficits may result in depletion of MSC pools, both in the bone marrow and in tissues</p><p>C. Depletion of the pericyte niche is exacerbated by a chronic, incompetent, wound repair response. Ultimately, this depletion will result in loss of microvasculature integrity and subsequent vascular events observed in HGPS, such as vascular stiffness and atherosclerosis.</p><p>E. In adipose tissue, the activation of MSCs located at the pericyte niche for addressing deficient wound repair response or osteogenesis, could lead to a deficient differentiation into adipocytes</p><p>F. Elaborating on proposed MSC interventions (Infante and Rodriguez, 2021) and current gene editing efforts (Koblan et al., 2021), targeting the bone marrow niche in young patients could rescue the later HGPS phenotypes.</p><disp-quote content-type="editor-comment"><p>13. A major shortcoming of this work is the drawing of conclusions on pathomechanisms of HGPS in multiple mesenchyme-derived tissues based on fibroblast transcriptional and epigenetic profiles which are, however, acknowledged by the authors. Specifically, changes in gene expression are attributed to alterations in compartment identity or lamina association in fibroblasts, but no data is provided to suggest those same changes occur identically in other cells or tissues where conclusions are being made. This requires further discussion in the paper.</p></disp-quote><p>We have now specifically stated this as a limitation, along with the statement that other tissues of the mesenchymal lineage are not available from Progeria patients and a discussion of the evidence of how fibroblasts may report on the state of the mesenchymal lineage.</p><p>To investigate how some key genes we highlight behave during differentiation from MSC to osteocyte or adipocyte lineages, we analyzed data from studies that induced WT MSC differentiation into these lineages (GSE37558 and GSE151324). We found cases in which the patterns of gene expression in this differentiation trajectory could potentially inform an interpretation of misregulation in Progeria, such as shown with FZD4 (<xref ref-type="fig" rid="sa2fig1">Author response image 1</xref>). This gene normally increases with osteoblast and adipocyte differentiation induction but stays aberrantly high in Progeria teens vs. WT teen and adult samples. However, in the process of this analysis, we identified a number of genes whose behavior was inconsistent between published datasets and thus likely sensitive to the source of MSCs and differentiation protocols. Further, taking into account the valid reviewer concerns that we do not want to appear to claim that we can comment on the Progeria MSC lineage directly, we decided it would add unhelpful confusion to include such data about comparisons to healthy MSC differentiation in the manuscript. Any conclusions we could draw from such comparisons would still be speculative, and therefore we have left further analysis in this direction to future work.</p><fig id="sa2fig1" position="float"><label>Author response image 1.</label><graphic mimetype="image" mime-subtype="tiff" xlink:href="elife-81290-sa2-fig1-v2.tif"/></fig><disp-quote content-type="editor-comment"><p>14. The manuscript would be strengthened by reorganizing the Results section to more clearly present the data pertaining to each of the five functional hubs that were found to be affected in HGPS cell lines in a linear manner.</p></disp-quote><p>In the revised manuscript we walk through 8 functional clusters that emerged from the comparisons of all HGPS children and teens to age-matched and adult controls: (1) DNA maintenance (2) Epigenetics (both discussed in Figure 1) (3) Tissue repair, (4) Extracellular matrix (Figure 2) (5) Bone (Figure 3) (6) Adipose tissue (Figure 4) (7) Blood vessel homeostasis (Figure 5) and (8) Muscle (Figure 6).</p><p>We then start a separate section to describe the results from a more detailed age stratification into infants and young children- stages where different phases of development are taking place. Here, we describe that for the youngest HGPS patients, epigenetic factors are most frequently misregulated, while for 4-7-year-old children, genes involved in ossification and chondrogenesis are most enriched in the misregulated set (Figure 7). We hope this separation of the sections clarifies the results.</p></body></sub-article></article>